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1 SUMMARY 
T cells, which are crucial effector cells of the adaptive immune system, develop in the 
thymus from common lymphoid progenitor cells. Each T cell carries a unique T cell 
receptor (TCR), generated during thymic development by random rearrangement of a 
number of gene fragments. Using this mechanism an enormous variety of TCR 
specificities can be generated, equipping T cells with the ability to react against every 
possible pathogen. However, with a certain probability TCRs recognizing self antigen 
will arise. These autoreactive T cells are mainly purged from the repertoire by the 
process of negative selection, but still some of them escape from the thymus to the 
periphery. To keep them in check, so called regulatory T cells (Treg) exist. Treg are 
characterized by the constitutive expression of the Interleukin-2 receptor α-chain 
(CD25) and the X-chromosome encoded transcription factor Foxp3 (Forkhead box P3), 
the latter being crucial for their function. Disruption of Foxp3 in mice results in lethal 
autoimmunity at the age of 3-4 weeks, while Foxp3 mutations in humans cause the 
severe autoimmune disease IPEX (immune dysregulation, polyendocrinopathy, X-
linked). 
Treg can develop from conventional T cells in the periphery under certain conditions, 
but most Treg are generated in the thymus. It has been shown that this process can be 
initiated upon interaction with peptide-MHC class II complexes on medullary thymic 
epithelial cells (mTECs), but the precise mechanism underlying thymic Treg 
development remains enigmatic. 
This study was initiated to delineate the process of thymic Treg development. For this 
purpose a TCR transgenic mouse model was used, in which T cells specific for 
hemagglutin can be tracked on single cell level. In AIRE-HA × TCR-HA mice, which 
express hemagglutinin (HA) under control of the Aire promotor specifically in mTECs 
T cells expressing the hemagglutinin specific TCR are efficiently selected into the Treg 
lineage. 
By intrathymic transfer of naïve TCR-HA+ RAG2-/- thymocytes into AIRE-HA recipients 
we could demonstrate that induction of CD25+ Foxp3+ Treg at the CD4+ single positive 
(SP) stage of T cell development is possible. The efficacy of Treg induction was 
affected both by the maturational stage of the transferred cells and the level of cognate 
antigen expression. Using in vivo intrathymic transfer and in vitro experiments, CD25- 
Foxp3- GITR+ and CD25+ Foxp3- CD4+ SPs were identified as precursor cells capable 
of developing to Foxp3+ Treg without the requirement for any further TCR stimulus. 
Elucidating the mechanistic details of these processes would be greatly facilitated by a 
suitable in vitro system closely mimicking the in vivo situation. We could show that 
thymic dendritic cells (DCs) and mTECs are capable of converting naïve CD4+ SPs to 
Foxp3+ Treg in vitro, providing a system in which easy manipulation is possible. 
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2 ZUSAMMENFASSUNG 
T-Zellen sind wichtige Zellen des adaptiven Immunsystems und entwickeln sich im 
Thymus aus lymphoiden Vorläuferzellen. Jede T-Zelle besitzt einen einzigartigen T-Zell 
Rezeptor (TCR), der während der Entwicklung im Thymus durch zufälliges Umstellen 
bestimmter Genfragmente entsteht. Durch diesen Mechanismus kann eine gigantische 
Vielfalt an verschiedenen TCR-Spezifitäten gebildet werden, wodurch T-Zellen jeden 
möglichen Krankheitserreger erkennen können. Allerdings entstehen mit einer 
gewissen Wahrscheinlichkeit auch TCRs, die körpereigene Antigene erkennen. Diese 
autoreaktiven T-Zellen werden großteils durch negative Selektion entfernt, aber einige 
wenige gelangen vom Thymus in die Peripherie. Um diese zu kontrollieren, existieren 
sogenannte regulatorische T-Zellen (Treg), die durch folgende zwei Merkmale 
charakterisiert werden: Expression der α-Kette des Interleukin-2 Rezeptors (CD25) und 
des X-chromosomal kodierten Transkriptionsfaktors Foxp3 (Forkhead box P3). 
Letzterer ist essentiell für die Funktion von Treg. Entfernung des Foxp3-Gens führt in 
Mäusen 3-4 Wochen nach der Geburt zu einer tödlichen Autoimmunerkrankung, 
während in Menschen Foxp3 Mutationen für die Autoimmunerkrankung IPEX (immune 
dysregulation, polyendocrinopathy, X-linked) verantwortlich sind. 
Treg können unter gewissen Umständen aus normalen T-Zellen in der Peripherie 
entstehen, aber die meisten Treg entwickeln sich im Thymus. Dieser Prozess kann 
durch Antigenerkennung auf thymischen medullären Epithelzellen (mTEC) ausgelöst 
werden, wobei die exakten Mechanismen noch unklar sind. 
In dieser Studie sollten Einblicke in die Treg Entwicklung im Thymus gewonnen 
werden. Dazu wurde ein TCR-transgenes Mausmodell verwendet, in dem individuelle 
T-Zellen, die spezifisch für Haemagglutin sind, verfolgt werden können. In AIRE-HA × 
TCR-HA Mäusen, die das Protein Haemagglutinin (HA) unter der Kontrolle des Aire 
Promotors exprimieren, entwickelt sich ein Teil der HA-spezifischen T-Zellen zu Treg. 
Durch intrathymischen Transfer von naiven TCR-HA+ Thymocyten in AIRE-HA Mäuse 
wurde gezeigt, dass die Entwicklung von CD25+ Foxp3+ Treg während des CD4+ 
positiven Stadiums der T-Zell Entwicklung möglich ist. Die Effizienz dieses Prozesses 
war einerseits vom Reifestadium der T-Zelle und andererseits auch vom Level der 
Antigenexpression abhängig. Sowohl durch intrathymischen Transfer in vivo als auch 
durch in vitro Experimente konnten CD25- Foxp3- GITR+ und CD25+ Foxp3- 
Thymocyten als Vorläuferzellen von Foxp3+ Treg charakterisiert werden. Für deren 
Entwicklung war eine weitere TCR-Stimulation nicht notwendig. 
Die Aufklärung von mechanistischen Details der Treg Entwicklung würde sich deutlich 
vereinfachen, wenn ein passendes in vitro System zur Verfügung stehen würde. In 
dieser Arbeit konnte gezeigt werden, dass thymische dendritische Zellen und mTEC in 
vitro CD4+ Thymocyten zu Foxp3+ Treg konvertieren, was ein einfaches 
experimentelles System für Modifikationen darstellen könnte. 
 
3 INTRODUCTION 
3.1 THE IMMUNE SYSTEM 
The immune system is the body’s defense system against pathogenic bacteria and 
viruses. For this purpose two distinct mechanisms have evolved, namely the adaptive 
and the innate immune system, the latter being evolutionarily older and thus present in 
all animal species.  
Innate immunity mainly works by recognizing conserved structures common for 
pathogenic organisms, also known as PAMPs (pathogen associated molecular 
pattern). Thus, the innate immune system can react immediately to a wide range of 
pathogens, but does not offer specificity or immunological memory. 
For this purpose, higher vertebrates have evolved adaptive immunity. Consisting of a 
variety of highly specialized cells, the adaptive immune system offers both the ability to 
attack every single pathogenic organism in a very specific manner, and immunological 
memory. To do so, a complex machinery has evolved in which immune cells randomly 
generate receptors by somatic rearrangement of certain gene fragments, thus giving 
the immune system the ability to react against every possible antigen. 
The two effector cell types equipped with these skills are T cells and B cells. The latter 
are generated in the bone marrow and responsible for the production of antibodies, 
which mark antigens for attack by other immune cells and the complement system. In 
contrast, T cells play a vital role not only by directly attacking bacteria, but rather by 
controlling central processes in an antigen dependent manner. 
Several subclasses of T cells can be distinguished, among them CD4+ T cells, which 
comprise a subset of so called regulatory T cells (Treg), the latter being of special 
interest to this work. Furthermore, CD8+ cytotoxic T cells (TC), natural killer T cells 
(NKT) and γδ T cells are known. These cells fulfill different specialized functions, but all 
of them are generated in the thymus from common lymphoid progenitor cells. The next 
chapter focuses on the process of T cell development in the thymus. 
 
 
3.2 T CELL DEVELOPMENT IN THE THYMUS 
The thymus is a two-lobed organ situated just below the upper end of the sternum. It 
can be morphologically divided into a cortical and medullary region, surrounded by a 
capsule. Since ancient beliefs claimed the thymus to represent the seat of the soul its 
physiological function was a matter of debate, until it could be shown in the early 1960s 
that the thymus is essential for the generation of mature T lymphocytes [3]. 
In contrast to the bone marrow, the thymus does not contain self-renewing stem cells, 
but is rather dependent on the periodic import of hematopoietic progenitor cells. These 
common lymphoid progenitor cells (CLPs) are produced in the bone marrow, circulate 
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 through the blood and enter the thymus at the cortico-medullary junction [4]. During a 
series of complex developmental steps T cell progenitor cells travel through the thymic 
compartments and leave the thymus as mature CD4+ or CD8+ T cells after roughly 20 
days. 
 
 
3.2.1 THE DOUBLE NEGATIVE STAGE 
Initially, common lymphoid progenitors are not committed to the T cell lineage and 
termed double negative (DN) cells or pro-T cells.  Their T cell receptor (TCR) genes 
are still in germline configuration, and they neither express CD3 nor the CD4/CD8 
coreceptors [5]. According to expression of CD25 and CD44 DN cells can be 
subdivided into four stages: DN1 (CD25- CD44+), DN2 (CD25+ CD44+), DN3 (CD25+ 
CD44low) and DN4 (CD25- CD44low) [6]. Development along these stages takes place 
while the cells migrate outward through the cortex into direction of the capsule. 
After extensive proliferation at the DN1 stage it is at the late DN2 and early DN3 stage 
that commitment to the T cell lineage occurs. At this point developing thymocytes start 
to upregulate expression of the RAG enzymes (recombination activation gene) to 
rearrange their T cell receptor (TCR) genes, namely the α- and β-genes for αβ-T cells. 
The differentiation of γδ-T cells will not be discussed in any further detail as these 
comprise only a minority of the mature T cell repertoire. 
The TCR β gene locus is rearranged first. It consists of a number of V-, D- and J gene 
segments, which are rearranged randomly through the action of RAG-1 and RAG-2 to 
yield a continuous in-frame VDJ gene sequence expressed as the TCR β chain. This 
polypeptide pairs with an invariant pre-T α chain to yield the pre-T cell receptor 
complex, an event representing the first developmental checkpoint for αβ-T cells known 
as β-selection. Signaling through the pre-TCR, which seems to be cell intrinsic [7], is 
essential for survival of the developing thymocyte, and cells that fail to successfully 
rearrange their TCR β genes die by apoptosis.  
As a result of pre-TCR expression a series of profound changes is initiated: suspension 
of VDJ gene rearrangement at the second TCR β allele, extensive proliferation and 
upregulation of CD4 and CD8 expression on the mRNA level [6]. Within a next step, 
rearrangement of the TCR α gene locus is started, which comprises only V and J 
segements.  Functional TCR α chains replace the pre-T α chain and form together with 
the β chain a mature T cell receptor. Concurrent with expression of CD4 and CD8 on 
the cell surface this event marks the transition from the DN to the double positive (DP) 
stage. 
 
 
3.2.2 THE DOUBLE POSITIVE STAGE AND POSITIVE SELECTION 
DP thymocytes reside in the subcapsular region of the cortex and closely interact with 
cortical epithelial cells (cTECs) while undergoing positive selection. Basically, positive 
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selection refers to the process in which DP thymocytes recognizing peptide-MHC 
(major histocompatibility complex) molecules presented by cTECs with low affinity 
receive a survival signal and continue to develop, while those cells that fail to bind self-
MHC molecules die by apoptosis. This developmental checkpoint ensures that mature 
T cells do have the ability to interact with self MHC molecules. Elegant experiments 
addressing this issue were done in the late 1970s showing that the developmental 
environment determines the MHC restriction of T cells [8]. Thymocytes of mice 
deficient in the TCR α chain do not develop past the DP stage demonstrating that a 
functional TCR is essential [9]. 
DP thymocytes comprise up to 80 to 90 % of thymic cellularity, but only 5-10% of these 
cells survive the positive selection checkpoint [10] [11] and continue to develop either 
to CD4+ or CD8+ SPs, while they migrate back through the cortex into direction of the 
medulla. Depending on whether the TCR recognizes MHC class I or class II molecules 
one of the coreceptors must be specifically downregulated, as CD4+ T cells exclusively 
recognize antigens presented in the context of MHC class II, while CD8+ T cells bind to 
MHC class I molecules. 
There are different models explaining this process. The instructive model states that 
appropriate TCR-MHC interactions determine expression of the correct coreceptor, 
while the stochastic model implies that expression of CD4 and CD8 is regulated 
randomly, followed by survival of cells with the correct MHC restriction of the TCR. 
Recently, a third model has been suggested. According to this work, after positive 
selection expression of CD8 is downregulated yielding CD4+ CD8int cells which remain 
uncommitted. Development to CD4+ SPs occurs if TCR signalling continues, while a 
diminished TCR signal results in development to CD8+ SPs [12]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Route of developing T cells in 
the thymus (adapted from [2]) 
Common lymphoid progenitor cells enter 
the thymus from the blood stream at the 
cortico-medullary junction (a). During 
migration through the cortex outwards they 
mature from DN to DP cells while 
interacting with cortical epithelial cells (b 
and c). At the DP stage only thymocytes 
that are positively selected survive, while 
other cells undergo apoptosis (d). As a next 
step, the CD4/CD8 lineage decision is 
made followed by migration into the thymic 
medulla (e). 
In the medulla single positive thymocytes 
interact with medullary epithelial cells (g) 
and are negatively selected or continue to 
mature, finally leaving the thymus in an 
S1P1 dependent fashion (g). 
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 3.3 AUTOREACTIVITY AND TOLERANCE 
After the CD4/CD8 lineage decision has been made, SP thymocytes migrate into the 
medulla, where they are going to interact with medullary epithelial cells (mTECs) and 
dendritic cells (DCs). During their residence time in the medulla SPs continue to mature 
and undergo stringent selection processes to ensure tolerance to self antigen, which 
will be discussed in the next chapter. Finally, cells leave the thymus as mature T cells 
via chemotaxis to S1P1, a chemoattractant abundant in the circulation [13]. An 
overview of thymocyte development from the DN stage to the SP stage, depicting 
stages and interacting cell types is given in Figure 1. 
Positive selection ensures that only those thymocytes binding to self MHC molecules 
survive. Another issue of crucial importance in T cell development is negative selection. 
Due to the random rearrangement of TCR gene fragments there is a certain probability 
that receptors strongly reacting with self antigen will arise. As these cells could initiate 
fatal autoimmunity, three mechanisms exist to deal with this problem: clonal deletion, 
anergy and receptor editing [14].  
During clonal deletion apoptosis is induced in thymocytes expressing receptors with 
high affinity for self antigen-MHC molecules. This process can occur both at the DP 
and early SP stage and clears a high proportion of self reactive thymocytes, thus 
making it one of the key mechanisms of central tolerance [15]. 
 
 
3.3.1 CENTRAL TOLERANCE 
In general, the term tolerance covers all processes that shape the repertoire of the 
adaptive immune system in such a way that it remains tolerant against self 
components. One can distinguish between central tolerance, which involves processes 
during early lymphocyte development, and peripheral tolerance, which acts on mature 
immune cells by mechanisms like anergy or ignorance. 
Since the visionary Frank Macfarlane Burnet published his thoughts regarding the 
clonal selection theory in 1957 [16, 17, 18], establishment of tolerance has been one of 
the most fundamental immunological questions. Much light has been shed on this 
puzzle since that, and it is now widely accepted that central tolerance is the most 
important mechanism, acting by recessive and dominant mechanisms. As mentioned 
above, recessive tolerance involves clonal deletion, anergy and receptor editing, 
thereby efficiently purging the T cell repertoire of self reactive cells [14]. 
The existence of clonal deletion as a key component of recessive tolerance could be 
confirmed only two decades after Burnet’s postulation of this process. In two 
independent key experiments it was demonstrated that first, T cells specific for the 
MHC molecule I-E are absent in I-E expressing mice [19] and second, TCR-transgenic 
cells specific for the male antigen H-Y are deleted in male, but not in female mice [20]. 
It was known that some self-reactive lymphocytes might escape clonal deletion, but 
peripheral tolerance mechanisms such as anergy were thought to keep them in check. 
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After initial descriptions of suppressive immune cells in the 1970s [21] it was only in the 
late 1980s that evidence for the existence of dominant (i.e. trans-acting) tolerance 
mechanisms was provided by experiments in chicken, which showed that beside 
central tolerance being induced by thymic epithelium only a small fraction of peripheral 
T cells is sufficient for control of self-reactivity [22]. 
For the mouse system, similar landmark experiments were published in 1990 [23]. 
Within this work, embryonic thymi from C3H mice (haplotype H-2k) were transplanted to 
nude BALB/c mice (C3H → BALB/cnu/nu) at the age of 1-10 days, allowing T cell 
development in the transplanted thymus. Subsequently, either C3H, BALB/c or C57Bl/6 
skin grafts were transplanted to C3H → BALB/cnu/nu chimeras and control BALB/cnu/nu 
mice. In the chimeras, BALB/c and C3H grafts were accepted, while C57Bl/6 grafts 
were all rejected, demonstrating that the transplanted thymic epithelium confers 
tolerance to both C3H and BALB/c. Importantly, T cells from C3H → BALB/cnu/nu 
chimeras retained the ability to react with C3H lymphocytes while accepting the skin 
grafts, definitely showing that clonal deletion can not be the only tolerance mechanism 
involved. 
Due to this and other work the existence of a specific cell type which is able to 
suppress autoimmunity and generated in the thymus was postulated. This form of 
trans-acting tolerance, in other words dominant tolerance, became known as the third 
function of the thymus [24]. 
However, how the thymus could tolerize the T cell repertoire against the huge variety of 
self antigens present in one organism remained a puzzle for several years. After 
reports suggesting transport of peripheral antigens into the thymus, key experiments in 
the Kyewski lab proved that there is indeed a cell type in the thymus, namely medullary 
thymic epithelial cells (mTECs), specialized for expression of otherwise tissue 
restricted antigens [25]. This phenomenon was termed promiscuous gene expression, 
and subsequent work identified the transcription factor Aire (autoimmune regulator) as 
an essential regulator of this process [26]. Aire was shown to drive transcription of a 
large number of tissue restricted antigens specifically in mTECs, emphasizing the 
crucial importance of this cell type in tolerance induction. Although the detailed 
molecular mechanism involved remains largely unknown, epigenetic mechanisms have 
been suggested to be involved [15]. 
 
 
3.3.2 REGULATORY T CELLS 
As mentioned above, first descriptions of T cells capable of suppressing immune 
responses date back to the 1970s [21], and work in the late 1980s strongly argued for 
the existence of suppressive immune cells. The absence of markers to identify such 
cells and the inability to define any suppressive factors misguided the scientific 
community to doubt the existence of regulatory immune cells [27].  Nevertheless, key 
experiments published by Shimon Sakaguchi in 1995 identified CD25 (the α chain of 
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 the IL-2 receptor) as a marker for a CD4+ T cell population that could control fatal 
autoimmune disease resulting from adoptive transfer of CD4+ CD25- T cells into nude 
mice [28]. 
These CD4+ T cells constitutively expressing CD25+ were named regulatory T cells 
(Treg), and interest into the field was rapidly revived. Subsequent work aimed at 
characterizing the properties of these cells. It could be shown that Treg are able to 
suppress the proliferation of both CD4+ CD25- and CD8+ naïve effector T cells in vitro. 
Nevertheless, Treg themselves remain anergic after TCR stimulation in vitro. This 
anergy can be broken by TCR stimuli in the presence of IL-2, but after removal of IL-2 
the cells return to their anergic state [29]. 
Contrary to these in vitro features, it could be shown in vivo that Treg proliferate 
extensively in an MHC class II dependent way when placed in a lymphopenic 
environment, but without losing their suppressive capacity [30 , 31]. More detailed 
studies applying cotransfer of TCR transgenic effector cells with Treg revealed that 
after immunization Treg indeed proliferate as much as effector T cells, but maintain 
their suppressive capacity in vivo and in vitro [32]. 
Beside that, CD4+ CD25+ Treg are unable to produce IL-2 or T-helper type 1 or type 2 
cytokines, and can be induced in vitro by the presence of transforming growth factor-β 
(TGF-β) [33], which will be discussed in more detail later. 
 
 
3.3.3 FOXP3 
One of the caveats of using CD25 as a marker for Tregs is that CD25 is upregulated by 
activated nonregulatory T cells as well. Thus, an important breakthrough in the field 
was the discovery of the gene for the X chromosome encoded transcription factor 
Foxp3 (Forkhead box P3). Foxp3 was initially discovered by genetic mapping of the 
gene responsible for the phenotype of scurfy (sf) mice, a spontaneous mouse mutant 
that shows overproliferation of T lymphocytes followed by death 3-4 weeks after birth 
[34]. At the same time, human patients suffering from a severe autoimmune disease 
called IPEX (immune dysregulation, polyendocrinopathy, X-linked) were shown to have 
a mutation in the Foxp3 gene [35]. A remarkable feature of these diseases is that only 
hemizygous males, but not heterozygous females are affected, implying that in females 
cells carrying the wildtype Foxp3 allele keep the mutant cells in check. This observation 
suggested a dominant mode of action, possibly involving regulatory T cells. 
Indeed, two years later both the Sakaguchi and the Rudensky lab showed that Foxp3 is 
specifically expressed in CD4+ CD25+ Tregs and essential for their development [36, 
37, 38]. Foxp3 knockout mice, as scurfy mice, lack regulatory T cells and die at the age 
of 3-4 weeks due to severe lymphoproliferation and aggressive autoimmune disease 
involving several organs, but can be rescued by adoptive transfer of Foxp3+ Tregs. 
Furthermore, reconstitution of lethally irradiated mice with wildtype and Foxp3-/- bone 
marrow showed that only Foxp3+ stem cells could give rise to Tregs. The crucial 
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function of Foxp3 was further underscored by the fact that ectopic expression of Foxp3 
with a retroviral vector in peripheral CD4+ effector cells confers suppressive function to 
them [36]. 
Handling Foxp3+ Treg was greatly simplified by the generation of mice expressing a 
fusion protein of Foxp3 and eGFP (enhanced green fluorescent protein), which allows 
the analysis of Foxp3 expression at the single cell level by flow cytometry [39]. Within 
this work it could be shown that T cell specific ablation of Foxp3 mimics the phenotype 
of Foxp3 null mice, suggesting that Foxp3 expression and function is limited to a 
subset of αβ-T cells. However, recent analysis by real-time PCR and 
immunohistochemistry showed expression of Foxp3 in non-lymphoid cells, namely in 
several epithelial cell types [40]. The functional importance of this findings remains to 
be clarified. 
Collectively, these results positioned Foxp3 as a master regulator of the Treg lineage 
and therefore much work has been attributed to the characterization of Foxp3 function 
in Treg biology, which will be discussed in detail in the next chapter. 
 
 
3.4 FOXP3 AND REGULATORY T CELL BIOLOGY 
3.4.1 FUNCTION OF FOXP3 IN TREGS 
To directly address the role of Foxp3+ Treg in tolerance maintenance an elegant knock-
in model was used [41, 42]. The sequence of the diphtheria toxin receptor (DTR) was 
inserted downstream of the Foxp3 gene (Foxp3DTR), making all Tregs expressing the 
DTR on their surface. Daily treatment of both newborn and adult Foxp3DTR animals with 
diphtheria toxin completely eliminated the Foxp3+ Treg population in these mice, 
leading to severe autoimmunity even more aggressive than observed in Foxp3 null 
mice, followed by rapid death within 10-24 days. This observation definitely proved that 
Tregs are absolutely crucial for the maintenance of tolerance throughout life while other 
possible mechanisms of peripheral tolerance are insufficient. 
At the same time the importance of Foxp3+ as a lineage specification factor was 
clarified. For this purpose a floxed Foxp3 allele was deleted in mature Foxp3+ Tregs by 
Cre-Lox mediated recombination. Unexpectedly, this resulted in the loss of suppressive 
function followed by production of IL-2 and pro-inflammatory cytokines such as TNF 
(tumor necrosis factor) and IFN-γ (interferon gamma) [43]. It was concluded that Foxp3 
is required to maintain Treg cell identity and does not simply induce a genetic program 
that sustains itself. 
A recent study focused on analysis of the TCR repertoire of conventional effector cells 
and Treg in TCR-β chain transgenic mice, showing that there are differences between 
conventional TCRs and thymic Treg. Importantly, in Foxp3-/- mice activated CD25+ T 
cells responsible for autoimmune reactions show considerable repertoire overlap with 
Treg in wildtype mice, suggesting that in the wildtype setting autoreactive thymocytes 
develop to Foxp3+ Treg [44]. 
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 On a molecular basis, two reports showed that both interaction with NFAT (nuclear 
factor of activated T cells) [45] and AML1/Runx1 (acute myeloid leukaemia 1 / runt-
related transcription factor 1) [46] is necessary for Foxp3 function. Interestingly, these 
transcription factors are involved in upregulation of IL-2, and interaction of Foxp3 with 
NFAT and AML1 reversed this function. According to these observations Foxp3 might 
mechanistically work by repressing alternative T cell fates through interaction with 
transcription factors that are involved. This idea is substantiated by the observation that 
the TGF-β dependent generation of Foxp3+ Treg antagonizes TGF-β/IL-6 dependent 
generation of pro-inflammatory IL-17 producing TH17 cells [47]. The reciprocal 
relationship between Foxp3+ Treg and TH17 cells expressing the orphan nuclear 
receptor RORγt has been emphasized by work published during preparation of this 
thesis [48]. 
More insight into the Foxp3 dependent regulation of Treg biology came from recent 
publications providing comprehensive gene profiling analysis. Two studies employed 
chromatin immunoprecipitation (ChIP) combined with mouse genome arrays to find 
direct targets of Foxp3. The Rudensky lab used ex vivo isolated Treg followed by ChIP, 
showing that Foxp3 directly binds to roughly 700 genes and acts both as a 
transcriptional repressor and activator [49], while the von Boehmer lab used Foxp3 
transduced murine hybridoma cell lines [50]. The latter study distinguished genes 
occupied by Foxp3 in unstimulated and stimulated cells, revealing that differential gene 
expression was far more pronounced in stimulated cells. However, both studies 
concluded that a high proportion of Foxp3 direct target genes are involved in T cell 
receptor signaling, suggesting that modulation of TCR signals is an important facet of 
Foxp3 function. 
A key aspect of Treg biology was revealed by the generation of knock-in mice 
expressing a nonfunctional Foxp3 allele together with eGFP (Foxp3KO-GFP) [51]. In 
heterozygous females, which carry one functional Foxp3 allele and one Foxp3KO-GFP 
allele, autoimmunity is kept in check by the WT Foxp3+ Treg population, thereby 
allowing the in vivo analysis of GFP marked “Treg” cells that actively transcribe Foxp3 
but lack the functional protein (further on called TFN cells). These TFN cells were not 
deleted in the thymus, and most unexpectedly, showed some Treg features, namely 
anergy and intermediate expression levels of CD25 and GITR. However, TFN cells were 
not suppressive and lost expression of the Foxp3GFP-KO after adoptive transfer. Gene 
expression analysis of TFN and Treg cells revealed that a proportion of the 
characteristic Treg expression profile was already present in TFN cells, meaning that 
Foxp3 is not necessary for initial induction of the Treg genetic program. 
Collectively these results show that Foxp3 amplifies Treg features which are already 
induced prior to Foxp3 expression. Thus, Foxp3 is of crucial importance for the fixation 
and maintenance of the Treg transcriptional program, but not for its induction. 
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3.4.2 THYMIC DEVELOPMENT OF REGULATORY T CELLS 
Since its initial discovery several aspects of Foxp3 function in Treg biology have been 
unraveled, but the main question of how Treg are generated remains unresolved. Early 
work in the 1970s has shown that thymectomy of wildtype mice 3 days after birth 
results in autoimmunity, which can be prevented by transfer of peripheral CD4+ CD25+ 
Treg [52]. Together with the observation of suppressive CD4+ CD25+ cells in the 
thymus [53] it is now widely accepted that mainly thymic processes are involved in Treg 
generation. However, peripheral conversion of T cells under certain conditions, for 
example in the gut [54] has been also shown to play an important role during the 
development of an immune response. 
During the last years, models using T cell receptor transgenic mice were used to 
address thymic Treg development. These models offer the significant advantage of 
tracking single T cells of known antigen specificity in vivo, while one possible caveat of 
these systems could be that expression of the transgenic TCR at inappropriate 
developmental stages may distort results [55]. 
In a first study published in 2001 mice expressing the TCR-HA (recognizing the 
peptide107-119 of influenza haemagglutinin in the context of I-Ed MHC-class II molecules) 
were crossed to mouse strains expressing the agonist HA-peptide under control of 
various promotors. Developing TCR-HA+ thymocytes underwent either deletion or Treg 
induction depending on the expression level of the ligand [56]. In a subsequent study 
DO11.10 mice, expressing a TCR specific for ovalbumin (OVA) were crossed to RIP-
OVA mice (expressing ovalbumin under control of the rat insulin promotor), 
recapitulating the Treg generation seen in the TCR-HA system [31].  
These results convincingly indicated that Treg can be induced in the thymus after 
interaction with peptide-MHC class II complexes, whereby the avidity of the interaction 
could play a decisive role. In this context an important aspect was provided by the 
subsequent observation, that costimulation via CD28 is required as well [57]. 
To gain a more detailed understanding of agonist induced thymic Treg development, 
recent work from our lab tried to elucidate the thymic cell type involved in antigen 
presentation [58]. For this purpose mice expressing influenza haemagglutinin (HA) 
under control of the Aire-promotor were generated (AIRE-HA), mimicking the 
physiological situation of Aire-dependent expression of self-antigens. Crossing of 
AIRE-HA mice to TCR-HA mice resulted in the induction of CD4+ CD25+ Foxp3+ Treg. 
By the generation of various bone marrow chimeras, it could be shown that antigen 
presentation by medullary thymic epithelial cells (mTECs) was indeed sufficient for 
Treg generation. In contrast, CD11c-driven antigen expression by dendritic cells (DCs) 
favoured deletion. 
The notion that agonist peptide-MHC class II complexes can induce Treg de novo was 
challenged by a publication in 2004 [59]. Using a transgenic TCR recognizing moth 
cytochrome c (TCR-MCC) in the context of an inducible tetracycline-system to drive 
expression of agonist MCC-peptide it was observed that increased levels of MCC 
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 yielded higher proportions of CD25+ Treg, but only a modest increase in absolute 
numbers. Accordingly, the authors speculated that Treg development is not instructed 
by TCR-MHC class II complexes, but occurs stochastically. 
 
 
3.4.3 FACTORS INFLUENCING THYMIC TREG DEVELOPMENT 
The molecular basis underlying the decision whether a thymocyte interacting with self 
peptide-MHC class II complexes undergoes deletion or Treg development remains a 
mystery.  
During the last years work from many labs focused on TGF-β, with the prevailing notion 
of its function undergoing several successive changes. Initially it was thought that 
TGF-β could play an important role in Treg development, as in vitro TCR stimulation of 
naive T cells in the presence of TGF-β is sufficient to induce Foxp3 [33] and TGF-β 
knockout mice die due to severe autoimmunity 3-4 weeks after birth [60]. 
Unexpectedly, analysis of young TGF-β knockout mice before the onset of any 
autoimmunity revealed roughly normal numbers of Foxp3+ Tregs in the thymus, but not 
in the periphery, suggesting that TGF-β is required for peripheral maintenance, but not 
for thymic generation of Tregs [61]. These results were further strengthened by the 
generation of mice with a T cell specific deletion of the TGF-β receptor II, where thymic 
Treg development was unaffected, but peripheral Treg numbers were reduced as well 
[62]. 
However, a recent publication challenged these results, revealing an intricate 
involvement of TGF-β [63]. Mice lacking TGF-β receptor-1 specifically in T cells 
showed nearly no Foxp3+ thymocytes at day 3 to day 5 after birth, but already 7 days 
after birth their number started to raise. In line with the known observations from TGF-β 
knockout mice, 2-3 weeks after birth normal numbers of Foxp3+ thymocytes were 
present. The boost in Foxp3+ thymocyte count was shown to depend on Interleukin-2 
(IL-2), another factor critical to Treg biology as discussed below.  
After IL-2 was initially discovered as a growth factor, the generation of both IL-2- and 
IL-2Rα- or IL-2Rβ- knockout mice suggested that IL-2 plays a crucial role in the 
prevention of autoimmunity [64, 65]. Afterwards, various groups tried to elucidate the 
importance of IL-2 signaling for Treg development, arguing for an essential function in 
the generation of CD4+ CD25+ Treg [66]. 
However, the unreliability of CD25 as a Treg marker challenged these results, and after 
the discovery of Foxp3 two studies re-addressed the significance of IL-2 for Treg 
biology. The Rudensky lab investigated polyclonal Treg development [67], while our lab 
followed agonist-driven Treg generation in IL-2-/- and IL-2Rα-/- mice [68]. Unexpectedly, 
it was found that thymic development of Treg was largely undisturbed in the absence of 
IL-2, with only a modest decrease observed in the polyclonal system. However, in both 
systems peripheral loss of Treg occurred, indicating a nonredundant role of IL-2 in 
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peripheral survival of Treg. Of note, IL-2 and IL-2Rα deficiency did not disturb in vitro 
suppression activity. 
Beside IL-2 there are other common γ-chain cytokines such as IL-7, IL-9 or IL-15, 
which require the common γ-chain cytokine receptor (CD132), signal via the JAK/STAT 
pathway and are collectively known to modulate survival and differentiation of 
developing lymphocytes [69]. Initial analysis of CD132 knockout mice showed a 
complete absence of Foxp3+ Treg [67], strongly arguing for a non-redundant role of this 
signaling pathway.  
A subsequent study extended this findings, showing that IL-2Rβ knockout mice had 
reduced numbers of Foxp3+ thymocytes, while in IL-2/IL-15 double knockout mice 
hardly any Foxp3+ thymocytes could be found [70]. As both in IL-2 or IL-15 single 
knockouts only a slight reduction of Foxp3+ thymocyte numbers was observed, this 
observation strongly suggests that IL-2 and IL-15 act as redundant factors during Treg 
development. On a molecular level, T cell specific deletion of STAT5 was shown to 
abrogate Treg development [70], unambiguously revealing the importance of cytokine 
signaling via the JAK/STAT pathway for Treg development. Furthermore, T-cell specific 
deletion of the MAP kinase TAK1, which is critical for integrating both TCR- and 
common γ-chain signals, results in nearly complete Treg deficiency [71]. 
On the level of TCR signaling some work focused on the role of the adaptor molecule 
LAT (linker of activated T cells). Mice with a specific amino acid substitution in LAT 
(replacing tyrosine 136 with phenylalanine, LATY136F) exhibit a partial block in late T cell 
maturation but still develop autoimmune disease. This was suggested to be due to a 
complete block in the development of Foxp3+ Treg, leading to the hypothesis that 
signaling via phospholipase Cγ1 is crucial for Treg development [72]. A recent 
publication cast doubt on this conclusions, showing that LATY136F mice do have 
nonfunctional Foxp3+ Treg that fail to control conventional mutant LATY136F CD4+ 
T helper cells [73]. 
 
 
3.4.4 ONTOGENY OF FOXP3+ TREG 
As thymectomy of 3-day old mice leads to autoimmunity which is attributable to a lack 
of Treg, one can speculate that the thymic generation of Treg is delayed in comparison 
to conventional T cells. After one report suggesting that this is not the case [74], 
detailed analysis of the kinetics of thymic Treg development in newborn Foxp3gfp mice 
revealed that the appearance of Foxp3+ Treg is indeed 3-4 days delayed in comparison 
to conventional nonregulatory T cells, which are already present at birth [75]. 
Beside that, this study showed interesting facets of Foxp3 induction which are probably 
applicable for adult thymic Treg development as well and therefore discussed in more 
detail. On day 1 and 2 after birth hardly any Foxp3+ cells, but instead a significant 
fraction of CD25+ Foxp3- cells can be detected. Although in terms of surface marker 
expression this population is not very similar to mature CD25+ Foxp3+ Treg [75], it is 
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 tempting to speculate that these CD25+ cells are direct Treg precursors. This 
hypothesis is substantiated by the above mentioned study of Foxp3KO-GFP cells which 
are CD25+ as well [51]. 
Additionally, analysis of CD4/CD8 expression of the few existing Foxp3+ thymocytes 
revealed that from day 1 on these cells mainly resided in the CD4+ single positive (SP) 
compartment. This observation argues against the induction of Foxp3+ Treg at the DP 
stage, which has been proposed by another study [76]. 
 
 
3.5 INTEGRATING CURRENT KNOWLEDGE ON TREG DEVELOPMENT 
The available data discussed so far allow the following conclusions: Mechanistically, 
high affinity interaction with peptide-MHC class II complexes, costimulation via CD28 
and signaling of common γ-chain cytokines are necessary. Both TGF-β and IL-2/IL-15 
seem to dictate Treg development in a delicate manner, with some redundancy 
between these factors. 
On a cellular level, Foxp3 expression is needed to sustain and amplify the Treg genetic 
signature, but is not required for induction of some Treg features such as anergy, 
upregulation of CD25 and low expression of IL-7Rα. 
Very recent reports provided more detailed insight into the mechanistic puzzle of Treg 
induction. In one study, via transduction of a constitutively active allele of AKT it could 
be shown that both TGF-β dependent conversion of transduced CD4+ T cells in vitro 
and thymic development of transduced DN thymocytes to Foxp3+ thymocytes in vivo 
are reduced. Downstream targets of AKT include the protein mTOR (mammalian target 
of rapamycin), and rapamycin treatment of in vitro cultures could partially reverse the 
effect of constitutively active AKT [77]. Thus, signaling via AKT-mTOR seems to 
negatively regulate Treg development. 
Another study readressed the importance of signaling via the the JAK/STAT pathway 
by transgenic mice expressing a constitutively active form of STAT5 [78]. In these 
mice, Foxp3+ thymocytes could be detected at day 1 after birth, which is not the case in 
wildtype mice (see section 3.4.4). Furthermore, constitutively active STAT5 drives Treg 
development in CD28-/- and CD132-/- (common γ-chain) mice which are normally 
devoid of Treg, as stated above. 
During preparation of this thesis another report was published, revealing that signals 
via the aryl hydrocarbon receptor (AHR) can define the decision whether peripheral T 
cells develop into Foxp3+ Treg or proinflammatory TH17 cells [79]. However, whether 
AHR plays a role in thymic Treg development remains to be tested. 
The current state of knowledge concerning signals involved in Treg development is 
summarized in Figure 2, combined with an overview of defining Treg features. 
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Figure 2: Signals required to induce Foxp3+ Treg cells (adapted from [1]) 
Signals unambiguously shown to be involved for thymic Treg development include TCR-, CD28- and 
common γ-chain cytokine signals, as illustrated at the left diagram. TGF-β has recently been 
suggested to play a more global role in Treg development than initially thought. 
Among the defining features of mature Foxp3+ Treg are suppressive function and constitutive 
expression of CD25 and GITR. Furthermore, they express low levels of IL-7Rα and are inable to 
produce both IL-2 and TH1/2 cytokines.  
 
 
 
 
 
 
 
 
 
3.6 AIM OF THE PROJECT 
As summarized above, some requirements for thymic generation of Treg have been 
experimentally addressed, but still the signalling pathways involved and the process 
per se remain enigmatic. Studying mechanistic details of thymic Treg development 
would be facilitated by the identification of direct precursor cells. 
Thus, the aim of this work was to identify developmental precursors of mature 
CD4+ CD25+ Foxp3+ Treg by using a TCR transgenic model. Additionally, by means of 
intrathymic transfer experiments we wanted to clarify at which stage of T cell 
development Treg induction takes place, thereby gaining a more detailed 
understanding of this process. 
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 4 MATERIALS AND METHODS 
4.1 MATERIALS 
4.1.1 BUFFERS AND MEDIA 
1x PBS:   8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4, 0.24 g KH2PO4, pH adjusted to 7.4  
FACS buffer:  1x PBS, 2% FCS (Gibco), 1 mM EDTA 
MACS buffer:  1x PBS, 0.5% BSA (Sigma Aldrich), 2 mM EDTA 
Collagenase/dispase medium: IMDM (Gibco), 0.2 mg/ml dispase 1 (Roche), 0.2 mg/ml 
collagenase (Roche), 2% FCS (Gibco), 25 mM Hepes pH 7.2 
Complete IMDM: IMDM (Gibco), 10% FCS (Gibco), glutamin, penicillin/streptamycin, 
β-mercaptoethanol 
 
1x PBS (further on referred to as PBS), 0.5 M EDTA, 10x TAE, 5 M NaCl, IMDM and 
RPMI were all obtained from the IMP media kitchen. 
 
 
4.1.2 PEPTIDES 
The influenza hemagglutinin peptide HA107-119 (SVSSFERFEIFPK, recognized by the 
TCR-HA in the context of I-Ed) and the ovalbumin peptide OVA323-339 
(ISQAVHAAHAEINEAGR, recognized by the DO11.10-TCR in the context of I-Ea) were 
synthesized in the IMP Protein Chemistry Facility. 
 
 
4.1.3 ANTIBODIES 
Abbreviations used for fluorescence molecules are Allophycocyanin (APC), 
Phycoerythrin (PE), Fluorescein isothiocyanate (FITC), Phycoerythrin-Cy7 (PE-Cy7), 
Allophycocyanin-Cy7 (APC-Cy7), Phycoerythrin-Cy5 (PE-Cy5, Cychrome). 
The following antibodies were all purchased from BD Biosciences: APC CD45.1 (clone 
A20), PE-Cy7 CD25 (clone PC61), APC-Cy7 CD4 (clone L3T4), APC CD4 (clone RM4-
5), PE CD4 (clone L3T4), Cychrome CD8 (clone 53-6.7), PE GITR (clone DTA-1), PE 
PD-1 (clone J43), Cychrome CD45 (30-F11), PE Ly51 (clone BP-1), FITC CD11c. 
Biotinylated antibodies against CD8, CD69 (clone H1.2F3), CD44 (clone IM7), CD24 
(clone 30-F1), CD103 and Qa2 (clone 1-1-2) were from BD Biosciences as well. 
Streptavidin conjugated to Cychrome, PE, APC and PE-Cy7 was also obtained from 
BD Biosciences. 
Monoclonal antibodies (mAb) to the TCR-HA (clone 6.5), TCR-OVA (clone KJ-26), 
against EpCAM (clone G8.8), CD4 (GK1.5) were purified from hybridoma supernatants 
and biotin- or fluorescence-labeled (Prozyme, following the manufacturer’s protocol) in 
our lab. Neutralizing anti-mouse TGF-β1/2 (clone 1D11.16) was also purified from 
hybridoma supernatants in our lab. 
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All antibodies were titrated (2-fold dilution series from 1:50 down to 1:3200) and 
subsequently used in the optimal concentration. 
Ki67 (clone B56) and Annexin-V stainings were done according to the manufacturer’s 
instructions (BD Biosciences). 
 
 
4.2 MICE AND GENOTYPING PROCEDURES 
4.2.1 MICE 
All mice used were on BALB/c background, unless stated otherwise. AIRE-HA × 
TCR-HA mice have been described previously [58] and were bred to Foxp3GFP reporter 
mice [39], and additionally for some experiments to a CD45.1+/- background. Both 
DO11.10 and TCR-HA mice were bred to a RAG2-/- Foxp3gfp CD45.1+/- background. All 
AIRE-HA mice used for experiments were heterozygous. BALB/c mice were either bred 
in-house or purchased from Taconic. 
All animals were bred and maintained in the animal facility of the Research Institute of 
Molecular Pathology under pathogen-free conditions in individually ventilated cages. 
Animal studies were approved by local authorities (MA58) and were performed 
according to Austrian regulations. 
 
 
4.2.2 GENOTYPING 
For genotyping, mouse tails were clipped and digested in 50 µl of tail buffer for 6 hours 
at 55°C, followed by inactivation of enzymes at 95°C for 5 minutes. 1 µl of the digested 
template was used for subsequent PCR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tail buffer, volume 50 µl 
Reagent Volume [µl] 
10x Gitocher buffer 5 µl 
10% Triton-X 2.5 µl 
β-Mercaptoethanol 0.5 µl 
Proteinase K [10 mg/ml] 3 µl 
H2O 39 µl 
PCR reaction, volume 30 µl 
DNA template 1 µl 
Primermix [2.5 µM] 3 µl 
10x dNTPs [2.5 µM] 3 µl 
5x PCR buffer 6 µl 
Taq polymerase 1 µl 
H2O 16 µl 
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 10x Gitocher buffer 5x PCR buffer 
670 mM Tris pH 8.8 
166 mM Ammonium sulfate 
65 mM MgCl2 
0.1% Gelatin 
250 mM KCl 
50 mM Tris pH 8.3 
43% Glycerol  
7.5 mM MgCl2  
2 mM Cresol Red 
 
 
 
 
 
 
 
 
The following primers were used for the respective genotypes: 
 
TCR-HA: 5’  ACAAGGTGGCAGTAACAGGA 
 3’  ACAGTCAGTCTGGTTCCTGA 
DO11.10: 5’  CAGGAGGGATCCAGTGCCAGC 
 3’  TGGCTCTACAGTGAGTTTGGT 
RAG2:  5’  GCAACATGTTATCCAGTAGCCGGT 
3’  TTGGGAGGACACTCACTTGCCAGT 
int  GTATGCAGCCGCCGCATTGCATCA 
AIRE-HA: 5’  ACAGCCACTCCTGTCTTTGC 
 3’ CTCCGTCAGCCATAGCAAATTTCT 
AIRE-HCO: 5’  ACAGCCACTCCTGTCTTTGC 
 3’ GAATTGTTCGCATGGTAGCC 
FOXP3GFP 5’ AGACAGACCAGAGGTGTAGT  
 3’  TCCTGGGGATGGGCCAAGGGCCAAGG 
 
All genotyping PCRs were run with the following program (TD 54 × 30) and 
subsequently analyzed on a 1% agarose gel containing Ethidium bromide.  
 
94°C for 3:00 min 1 cycle 
94°C for 0:45 min 
60°C for 0:45 min  
72°C for 1:00 min 
 
 
2 cycles 
94°C for 0:45 min 
58°C for 0:45 min 
72°C for 1:00 min 
 
 
2 cycles 
94°C for 0:45 min 
56°C for 0:45 min 
72°C for 1:00 min 
 
 
2 cycles 
94°C for 0:45 min 
54°C for 0:45 min 
72°C for 1:00 min 
 
 
30 cycles 
72°C for 5:00 min 1 cycle 
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4.3 IN VITRO PROCEDURES 
4.3.1 FACS (FLUORESCENCE ACTIVATED CELL SORTING) ANALYSIS AND STAINING 
PROCEDURES 
Single cell suspensions of thymus, spleen or lymph nodes were prepared by gently 
mincing the organs between two glass slides and subsequent filtering through a cell 
strainer. Staining was performed according to standard procedures at a concentration 
of 1-4×106 cells in 100 µl FACS buffer (containing the appropriate antibodies) for at 
least 15 minutes on ice. Washing steps were performed by adding an excess of FACS 
buffer and centrifugation (5 minutes, 750g). Cells were filtered through a cell strainer 
prior to analysis. Flow cytometry was done on a FACSCanto (Becton Dickinson) 
followed by analysis with FlowJo (Treestar). Cell sorting was performed on a FACSAria 
(Becton Dickinson) into FCS-rinsed tubes. 
 
 
4.3.2 MACS DEPLETION 
Both for analysis of intrathymic injections and for sorting of CD4+ SPs, thymi had to be 
depleted of all CD8+ cells to yield cell numbers suitable for flow cytometric analysis.  
Single cells suspensions were prepared, counted (Casy Counter, Schärfe Systems) 
and incubated with 1 ml of biotinylated CD8-antibody solution for 15 minutes on ice. 
After one washing step cells were resuspended in Strepatividin Microbeads (Milteny) 
which were diluted 1:10 with MACS buffer. For 100×106 cells 20 µl of Microbeads were 
used. After incubation at 4°C for at least 15 minutes cells were washed and 
resuspended in 1 ml of MACS buffer. 
Cells suspensions were applied to pre-equilibrated MACS LS columns (Milteny), 
whereby thymi larger than 220×106 cells were split to two columns. Columns were 
rinsed 3 times with 3 ml of MACS Buffer, while the flowthrough was collected on ice. 
Cells were pelleted and stained for FACS as described in section 4.3.1. 
 
 
4.3.3 PKH26 LABELING 
For pkh26 labelling (Sigma Aldrich) 1-2×106 cells were washed two times with PBS and 
after complete removal of the supernatant resuspended in 100 µl of diluent C (Sigma 
Aldrich). 100 µl of 2x pkh26 solution were prepared (i.e. 1:500 pkh26 in diluent C to 
yield a final concentration of 1:1000) and added to the cell suspension. Cells were 
incubated for 3 minutes at room temperature and gently mixed every minute, followed 
by addition of 200 µl of FCS. After incubation for another minute, 400 µl of FACS buffer 
were added, and after centrifugation (5 min, 750 g, 4°C), the cells were resuspended 
either in FACS buffer or PBS and washed for an additional 2 times. All volumes were 
upscaled according to the used cell number (maximum 10×106). 
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4.3.4 CFSE LABELING 
1×107 cells in 1 ml of labeling buffer (PBS with 0.1% BSA) were incubated for 10 
minutes at 37°C with Carboxy-Fluorescein Diacetate Succinimidyl Ester (CFSE, final 
concentration 10 μM, Roche), followed by two washing steps either in FACS buffer or 
PBS. 
 
 
4.3.5 IN VITRO ASSAYS 
For in vitro assays, sorted T cells (either from TCR-HA RAG2-/- or DO11.10 RAG2-/- 
animals) were washed once with medium and then resuspended in complete IMDM. 
5 x 104 T cells and 2 x 104 antigen presenting cells (sorted mTECs or DCs, see section 
4.4.3) were cultured together in 96-well round-bottom plates in a final volume of 200 µl, 
unless stated otherwise medium was supplemented with 100 units/ml IL-2 
(Preprotech). If necessary, HA- or OVA-peptide was added. For some assays, the 
activin receptor-like kinase inhibitor SB-431542 (conc. 3µM) [80] or neutralizing anti-
TGF-β antibody (clone 1D11.16, conc 10 µg/ml) was used. Assays were stained for 
CD4 and CD25 and analyzed by flow cytometry 3-5 days later. 
 
 
4.3.6 ANTIGEN PRESENTATION ASSAYS 
For A5 antigen presentation assays, 2×104 sorted antigen presenting cells (either 
mTEC, DCs) were cultured with 2×104 A5 hybridoma cells in 200 µl IMDM including 1% 
FCS (Gibco) in 96-well round-bottom plates. If necessary, HA-peptide was added in a 
particular concentration. The assay was analyzed for expression of GFP by flow 
cytometry 17 to 20 hours later. 
 
 
 
4.4 IN VIVO EXPERIMENTS 
4.4.1 INTRATHYMIC TRANSFER 
Intrathymic (IT) transfer has been described first in 1986 [81] and was slightly 
optimized for our experiments. Cells for injection were sorted to a purity > 95%, 
washed twice with PBS and then carefully resuspended in sterile PBS to yield a 
concentration of 5×105 cells in 3 µl (unless stated otherwise). 
Recipient mice were anesthetesized with Ketamine / Xylazine intraperitoneally. After 
fixation of the animals with elastic straps, a small cut was made in the skin overlying 
the upper thoracic region, 2-4 mm above the sternum. Fat and connective tissue was 
carefully displaced and then the sternum was cut open for roughly 4 mm with fine 
scissors, thereby exposing the underlying thymus. Using a Hamilton syringe (Model 
600, volume 2.5 to 5 µl) arranged in a flat angle, 3 µl of cell suspension were directly 
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injected into the anterior superior region of one thymic lobe. Care had to be taken not 
to injure the heart by passing through the thymus Afterwards the incision was closed 
with wound clips. Survival rate was more than 97%. 
At various time points after transfer recipient animals were sacrificed, thymi were 
depleted of CD8+ cells as described in section 4.3.2 and stained for FACS analysis.  
 
 
4.4.2 BONE MARROW CHIMERAS 
Tibiae and femur were collected from donor animals and carefully cleaned from 
surrounding muscle and connective tissue. Bones were sterilized in 70% ethanol for 
2 minutes and washed with PBS. Then they were cut open at the ends and bone 
marrow (BM) was flushed out with PBS and the help of a syringe. Single cells 
suspensions were made by repeated resuspension, followed by filtering through a cell 
strainer. Finally, magnetic T cell depletion (using CD4 and CD8 antibodies) as 
described in section 4.3.2 was performed. 
Recipient mice were lethally split-dose irradiated (for BALB/c animals 2 times 450 rad, 
for F1 (BALB/c C57Bl/6) animals 2 times 500 rad) and reconstituted by intravenous 
injection with 5-8×106 T cell depleted BM cells. Chimeras were used for intrathymic 
transfer experiments 5-8 weeks later. 
 
 
4.4.3 PREPARATION OF THYMIC STROMA 
Thymi were collected followed by careful removal of fat and connective tissue. Organs 
were cut into pieces using small scissors and then transferred to 15 ml tubes (Falcon) 
and incubated with collagenase/dispase medium including DNAse (added prior to use, 
final conc. 25 µg/ml) at 37°C for 45 minutes. For each thymus, 0.5 to 0.75 ml of 
collagenase/dispase medium was used. 
To disrupt cell-cell interactions, the suspension was resuspended very frequently, first 
with a 1000 µl pipette, then using 5 ml syringes with microlance no. 5 needles (Becton 
Dickinson). After 45 minutes the digest was stopped by addition of EDTA to yield a final 
concentration of 5 mM and incubation for 5 minutes at 37°C. After EDTA incubation 
cells were transferred to ice immediately, washed with excess of FACS buffer and 
counted (Casy Counter, Schärfe Systems). After complete removal of the supernatant 
the pellet was carefully resuspended in high density percoll (GE Healthcare, ρ = 1.115). 
An intermediate layer of low density percoll solution (GE Healthcare, ρ = 1.045 – 1.06 
according to titration) followed by an upper layer of IMDM was very carefully pipetted to 
yield an inverse discontinous density gradient. 
After centrifugation at 1350 g for 30 minutes at 4°C (without brake, medium 
acceleration) low density cells (including mTECs and DCs) could be found within the 
upper interphase. Cells were removed using a 200 µl pipette, washed with FACS buffer 
und used for subsequent staining or sorting as described in section 4.3. 
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v1 … volume of stock solution 
v2 … volume of diluting solution 
D1 … density of stock solution 
D2 … density to reach 
D  … density of PBS
High density percoll was generated by diluting Percoll pure (GE Healthcare) with 10x 
PBS including 25 mM HEPES, low density percoll by diluting high density percoll with 
PBS. Calculation of densities was performed as follows: 
 
 
 
 
 
 
 
 
4.5 RNA WORK 
4.5.1 RNA ISOLATION 
Sorted cells were washed two times with PBS and then resuspended in 200 µl PBS. 
RNA was purified using the High Pure RNA isolation Kit from Roche according to the 
manufacturer’s protocol for RNA isolation from cultured cells. Final elution was 
performed in 50 µl elution buffer and RNA was either used directly for cDNA synthesis 
or stored at -80°C. 
 
 
4.5.2 CDNA SYNTHESIS 
cDNA was prepared using either SuperScript II First-Strand synthesis system 
(Invitrogen) or iScript cDNA synthesis kit (BioRad). For both kits the possible maximum 
amount of RNA template was used, following the manufacturers’ protocols. cDNA was 
stored at 4°C until further use. 
 
 
4.5.3 QUANTITATIVE REAL TIME PCR 
qPCR was performed using the Bio-Rad iQ SYBR Green Supermix. 7.5 µl of SYBR 
Green Supermix were mixed with 0.3 µl of the appropriate primer stock (10 µM, see 
primer list). 7.2 µl of cDNA template (duplicates) were pipetted into 96-well plates (Bio-
Rad), followed by addition of the primer-Supermix mixture and sealing of the plate with 
an optical qPCR film seal (Bio-Rad). qPCR was performed with a Bio-Rad iCycler using 
the following program:  
 
95°C for 3:00 min 1 cycle 
95°C for 0:45 min 
56°C for 0:45 min 
72°C for 1:00 min 
 
 
45 cycles 
55-95°C, 0.5 degrees 
change every 30 seconds 
melting curve 
D
D
−
− 21 )
D
D×=
2
1
2
(νν
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Analysis was performed with Bio-Rad iQ5 software and Microsoft Excel using the ΔΔCT  
method [82], while the correct size of the PCR fragment was verified on a 2% agarose 
gel. Primers used were as follows: 
 
Foxp3: 5’  TTCTCACAACCAGGCCACTTG 
 3’  ATCATGGAGAAGAGGCGAAGGG 
IL2Rα: 5’  CGGGATACAAGGCTCTA 
 3’  AAGTCTGTGGTGGTTATGG 
IL2Rβ:  5’  AGAAGGGTTGGCGTAG 
3’  TCTGGGTATCAATGTGC 
IL7Rα: 5’  CCCTCTGACCTGAAA 
 3’ TCTGTGGGATTGTTGT 
CTLA-4: 5’  TTTGTAGCCCTGCTCACT 
 3’ GGAAGCCCACTGTATTCTT 
SOCS-2 5’ TCGCATTCAGACTACCT  
 3’  CTGTCCGTTTATCCTTG 
Nrp-2 5’ TGATAGGGAAGGGACGAT  
 3’  TTCTTTGCCAGATGAGGG 
 
 
 
 
 5 RESULTS 
5.1 PHENOTYPIC CHARACTERIZATION OF THE AIRE-HA × TCR-HA SYSTEM 
5.1.1 REGULATORY T CELL INDUCTION IN A DOUBLE TRANSGENIC MOUSE MODEL  
As mentioned in the introduction, work from our lab [58] has shown that thymocytes 
expressing a transgenic class II-restricted αβ-T cell receptor specific for hemagglutinin 
(TCR-HA) give rise to CD4+ CD25+ regulatory T cells (Treg) if the agonist ligand 
hemagglutinin is presented by medullary thymic epithelial cells (mTECs) under control 
of the Aire promotor (AIRE-HA). 
Here we used AIRE-HA × TCR-HA mice to further characterize the process of thymic 
Treg development. To facilitate identification of Foxp3+ Treg cells AIRE-HA × TCR-HA 
mice were crossed to Foxp3gfp mice, which express a fusion protein of Foxp3 and 
eGFP (enhanced green fluorescent protein) [75]. Thus we were able to analyze and 
culture ex vivo isolated Foxp3+ cells without the need for intracellular staining. 
 
As already published [58], both TCR-HA and AIRE-HA × TCR-HA mice display normal 
thymic cellularity and no change in the percentage of CD4 single positive thymocytes 
(CD4+ SPs). In TCR-HA mice about 25% of CD4+ SPs stain positive for TCR-HA, and 
nearly all of these cells remain phenotypically naïve in terms of CD25 and Foxp3 
expression. In contrast, in AIRE-HA × TCR-HA mice only 5-10% of the cells at the 
CD4+ SP stage are TCR-HA+ (Figure 3). A significant fraction of these TCR-HA+ CD4+ 
SPs express CD25 and Foxp3 and have been characterized as being functional Tregs 
[58].  
 
 
 
 
 
 
 
 
 
 
Figure 3: CD4+ SP compartment of TCR-HA and AIRE-HA × TCR-HA thymi 
TCR-HA+ CD4+ SPs in TCR-HA mice are phenotypically naïve in terms of CD25 and Foxp3 (left dot 
plots). In contrast, TCR-HA+ CD4+ SPs in AIRE-HA × TCR-HA mice (right dot plots) can be divided into 
three subsets based on CD25 and Foxp3 expression (coloured light blue, red, and black). Note the 4-fold 
decrease of TCR-HA+ CD4+ SPs in AIRE- HA × TCR-HA thymi. 
Gating is denoted above dot plots, and given percentages for the indicated gates are mean values of 5 
(TCR-HA) and 30 (AIRE- HA × TCR-HA) mice aged  4-6 weeks, respectively.  
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Interestingly, there was also a population of cells expressing only CD25+ but not Foxp3. 
Appearance of CD25+ Foxp3- thymocytes has been described during ontogeny [75] 
and in Foxp3KO-GFP cells [51], but the fate of these cells has not been experimentally 
addressed until recently. Two opposing possibilities could be envisioned: CD25+ Foxp3- 
cells could represent either a “dead end” or an intermediate developmental step during 
Treg development. Using AIRE-HA × TCR-HA mice we wanted to address this issue 
and as a starting point analysed expression of various activation markers.  
For this purpose, CD4+ TCR-HA+ thymocytes from AIRE-HA × TCR-HA mice were 
separated into the following three subsets (Figure 3): CD25- Foxp3- (designated 
subset 1, blue), CD25+ Foxp3- (designated subset 2, red) and CD25+ Foxp3+ cells 
(designated subset 3, black). Results of flow cytometric analysis are discussed within 
the next paragraphs. 
 
 
5.1.2 ACTIVATION MARKERS 
Several surface molecules are known to be differentially regulated during activation of 
T cells. CD69 and CD44, markers indicative for T cell receptor (TCR) signalling, were 
found to be upregulated by CD25+ Foxp3- cells (Figure 4). Diminished CD69 levels 
within the CD25+ Foxp3+ subset suggest, due to the transient nature of CD69 
expression [83], a decrease in TCR triggering. 
The tumor-necrosis-factor-receptor family member GITR (glucocorticoid induced tumor 
necrosis factor receptor) is rapidly induced after stimulation of naïve T cells, and known 
to be constitutively expressed by Tregs [84]. Consistent with that high expression of 
GITR was detected on CD25+ Foxp3+ cells. CD25+ Foxp3- cells displayed slightly lower 
GITR levels, while for CD25- Foxp3- cells an unexpected biphasic expression pattern 
was observed, with 30-60% of cells expressing intermediate levels of GITR. This 
suggests that although being naïve in terms of CD25, these GITR+ cells have already 
been activated. 
Programmed death receptor 1 (PD-1) is expressed by a variety of immune cells and 
also upregulated on T cells within 24 hours after activation [85]. Both the CD25+ Foxp3- 
and CD25+ Foxp3+ subsets expressed intermediate levels of PD-1. Interestingly, as for 
GITR, upregulation of PD-1 by 20-40% of CD25- Foxp3- cells signified ongoing 
activation. Of note, co-staining for PD-1 and GITR revealed that within the CD25- 
Foxp3- subset not all GITR+ cells were PD-1+ and vice versa (data not shown). 
Inducible T cell costimulator (ICOS) belongs to the CD28 protein family and is 
upregulated after T cell activation as well [86]. In terms of ICOS expression no major 
differences could be detected between TCR-HA+ subsets, with only a few percent of 
CD25+ Foxp3+ being ICOS+. 
The function of CD103 (αE integrin) in Treg biology has not been clarified, although it 
has been reported to be involved in Treg function [87] and homing to epithelial 
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 compartments. In agreement with these reports a fraction of CD103+ cells within the 
CD25+ Foxp3+ compartment was observed. 
 
 
5.1.3 MATURATION MARKERS 
Since the analysis described above indicated different activation levels of TCR-HA+ 
cells in AIRE-HA × TCR-HA mice, we aimed to characterize the maturity of these 
subsets. For this reason stainings for maturation markers, which are differentially 
regulated during development of CD4+ SPs, were performed. CD62L (also known as 
L-selectin) and Qa-2 are known to be expressed at low to intermediate levels directly 
after transition from the double positive compartment, while mature CD4+ SPs increase 
expression of these molecules. In contrast, CD24 expression is known to decline with 
increasing maturity of CD4+ SPs [6]. For all these markers we detected an increase in 
maturity from CD25- Foxp3- to CD25+ Foxp3- and CD25+ Foxp3+ cells, with the largest 
differences between the latter two subsets (Figure 4). 
 
Figure 4: Expression of activation and maturation markers by TCR-HA+ CD4+ subsets in 
AIRE-HA × TCR-HA mice. 
All plots are gated on TCR-HA+ CD4+ CD8- thymocytes. Color code for histograms is as shown in 
Figure 1 with light blue for CD25- Foxp3-, red for CD25+ Foxp3- and black for CD25+ Foxp3+ cells. 
Grey shaded histograms represent TCR-HA+ CD4+ SPs from TCR-HA mice. Stainings have been 
repeated three times with similar results. 
 
 
 
 
 
 
 
 
 
´ 
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In conclusion, the expression analyses of the depicted activation and maturation 
markers suggest a developmental precursor-progeny relationship between the three 
subsets of TCR-HA+ CD4+ SPs in AIRE-HA × TCR-HA mice. To gain additional insight 
into this potential relationship we wanted to assess proliferation and apoptosis within 
these subsets. 
 
 
5.1.4 PROLIFERATION AND APOPTOSIS 
To test whether CD25+ Foxp3- cells are destined for negative selection an Annexin-V 
staining was carried out. Annexin-V binds to Phosphatidylserin molecules, which are 
normally found only in the inner layer of the cell membrane lipid bilayer. In cells 
undergoing apoptosis, one of the earliest events is flipping of Phosphatidylserine to the 
outer membrane leaflet, where it can be bound by Annexin-V. 
In comparison to naïve TCR-HA+ CD4+ SPs from TCR-HA mice, a 4- to 5-fold increase 
in apoptosis was seen both in TCR-HA+ CD25- Foxp3- and CD25+ Foxp3- cells from 
AIRE-HA × TCR-HA mice (Figure 5b). This finding does neither establish nor exclude 
the possibility that one of these subsets is undergoing negative selection. Of note, the 
percentage of cells undergoing apoptosis in vivo might be underestimated by these 
stainings because in the thymus apoptotic cells are rapidly cleared by resident 
macrophages [88]. 
As our analysis of activation markers indicated ongoing TCR-signaling, we wanted to 
address the proliferative status of CD4+ SPs in AIRE-HA × TCR-HA mice. For this 
purpose stainings for KI-67, a proliferation marker, were done. Both within the 
CD25- Foxp3- and CD25+ Foxp3- population up to 30% of cells were proliferating, 
indicating that CD25- Foxp3- cells are indeed not naïve but already activated (Figure 
5a). 
Figure 5: Analysis of proliferation and apoptosis within TCR-HA+ CD4+ subsets in 
AIRE-HA × TCR-HA mice. 
a Intracellular staining for the proliferation marker KI-67. Histograms are gated on TCR-HA+ 
CD4+ CD8- thymocytes, color code is as in Figure 2 (light blue for CD25- Foxp3-, red for CD25+ 
Foxp3- and black for CD25+ Foxp3+ cells, grey shaded for TCR-HA+ CD4+ SPs from TCR-HA 
mice) b Percentage of cells staining positive for KI-67 (left diagram) and Annexin-V (right 
diagram) in TCR-HA+ subsets from AIRE-HA × TCR-HA mice. Mean values from three 
independent experiments are shown. 
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 5.1.5 FOXP3 MRNA EXPRESSION IN FOXP3- SUBSETS 
We asked next whether the upregulation of CD25 was only the result of conventional 
activation due to antigen exposure or indicative of development along the Treg lineage. 
For this purpose, TCR-HA+ CD4+ SPs from AIRE-HA × TCR-HA mice were separated 
into the following subsets based on expression of CD25, Foxp3 and GITR: CD25- 
Foxp3- GITR-, CD25- Foxp3- GITR+, CD25- Foxp3+ and CD25+ Foxp3+. Cells were 
sorted, and after RNA isolation and cDNA synthesis quantitative real-time PCR was 
performed. 
Analysis of Foxp3 expression by qPCR revealed that in comparison to naïve 
CD4+ SPs, upregulation of Foxp3 on mRNA level could already be detected both within 
CD25+ Foxp3- and CD25- Foxp- GITR+ cells (Figure 6). One can conclude that signaling 
events inducing expression of Foxp3 are taking place within these subsets which 
supports the hypothesis that the Foxp3- subsets seen in AIRE-HA × TCR-HA mice are 
precursors of mature Treg. 
Beside that, changes in the expression of IL2Rα (CD25), IL2Rβ, IL7Rα, CTLA-4 and 
SOCS-2 were detected, all indicating ongoing TCR- and cytokine signaling events 
(data not shown). 
 
 
 
 
 Figure 6: qPCR analysis of Foxp3 expression within TCR-HA+ 
CD4+ SPs in AIRE-HA × TCR-HA mice. 
TCR-HA+ CD4+ SPs were separated based on expression of CD25, 
Foxp3 and GITR as denoted. Y-axis represents fold changes with 
expression being normalized to CD25+ Foxp3+ cells (arbitrary set to 1) 
using the ΔΔCT  method and β-actin as a housekeeping gene. Values 
represent the mean of three independent experiments. 
 
 
 
 
 
 
 
 
5.2 PRECURSOR-PROGENY RELATIONSHIP 
5.2.1 INTRATHYMIC TRANSFER OF SORTED TCR-HA+ SUBSETS  
The data presented so far argue for a precursor-progeny relationship within the subsets 
of TCR-HA+ CD4+ SPs in AIRE-HA × TCR-HA mice. However, the assumption that 
CD25+ Foxp3- cells represent a “dead end” can not be dismissed because staining for 
Annexin-V did not allow unambiguous conclusions. To definitely address this issue 
intrathymic transfer experiments were conducted. 
CD25- Foxp3- GITR-, CD25- Foxp3- GITR+ and CD25+ Foxp3- cells were sorted from 
the TCR-HA+ CD4+ compartment of AIRE-HA × TCR-HA Foxp3GFP CD45.1 mice and 
intrathymically injected into both AIRE-HA (CD45.2) and WT (CD45.2) recipients. Note 
that transfer of CD25+ Foxp3+ cells is not discussed here because as expected more 
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than 90% of cells retained their phenotype upon transfer (data not shown), which has 
already been reported for Foxp3+ Treg earlier [1]. 
Analysis four days after transfer revealed that in AIRE-HA recipients all transferred 
subsets gave rise to CD25+ Foxp3+ Treg, notably with stepwise increasing efficiency 
from CD25- Foxp3- GITR- to CD25- Foxp3- GITR+ and CD25+ Foxp3- cells (Figure 7). 
This observation provides additional evidence for a precursor progeny relationship 
between these subsets, and precludes the possibility that all cells of a particular subset 
represent a developmental dead end. 
Interestingly, after injection into WT animals both CD25- Foxp3- GITR+ and CD25+ 
Foxp3- cells gave rise to Foxp3+ cells as well. Thus, at least for a fraction of cells within 
these subsets TCR-stimulation is no longer necessary to continue their development. 
In contrast, CD25- Foxp3- GITR- stayed phenotypically naïve in the absence of TCR 
signaling (Figure 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: All TCR-HA+ CD4+ subsets from AIRE-HA × TCR-HA mice can give rise to Foxp3+ Treg 
after intrathymic transfer into AIRE-HA recipients. 
CD25- Foxp3- GITR-, CD25- Foxp3- GITR+ and CD25+ Foxp3- cells were sorted from the TCR-HA+ 
CD4+ SP compartment of AIRE-HA × TCR-HA Foxp3GFP CD45.1 mice and intrathymically transferred 
(3 x 105 cells per subset) into AIRE-HA and WT recipients. Analysis for Foxp3 and CD25 expression 
was performed four days after transfer. 
a Contour plots are gated on transferred cells (TCR-HA+ CD4+ CD8- CD45.1+) and representative of 
two independent experiments. Genotypes of recipient mice are indicated to the left, injected cell type 
above plots. Numbers in the plots indicate mean percentage (n=3-5) of CD25+ Foxp3+ cells. b Mean 
percentage of CD25+ Foxp3+ cells after intrathymic transfer into AIRE-HA (black bars) and WT (open 
bars) mice. Values are mean of 3-5 mice per group. 
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 5.2.2 POLYCLONAL CD25+ FOXP3- THYMOCYTES GIVE RISE TO FOXP3+ TREG 
To ensure that our observations are not the result of some predisposition of the TCR-
HA system we asked whether we could reproduce our results using polyclonal 
thymocytes. 
GITR staining of polyclonal CD4+ SPs reveals that not all of them are GITR negative, 
but that there is a large proportion of cells expressing intermediate levels of GITR [89]. 
Thus, we sorted polyclonal CD25- Foxp3- GITRlow, CD25- Foxp3- GITRhigh and CD25+ 
Foxp3- cells (note that gating for GITR was set arbitrary to choose the lowest and 
highest GITR expressing cells within the CD25- pool) followed by intrathymic injection 
into WT mice. 
Recipients were analyzed six days later, revealing that the results resembled the TCR-
transgenic system, with both CD25- Foxp3- GITR+ and CD25+ Foxp3- cells giving rise to 
Foxp3+ cells (Figure 8). Of note, in contrast to the TCR-HA system, polyclonal CD25- 
Foxp3- GITRlow developed to Foxp3+ Treg as well. While HA-specific thymocytes can 
not encounter their cognate antigen within WT mice, polyclonal thymocytes will do so 
with a certain probability. The population of CD25+ Foxp3- cells in these recipient mice 
expressed lower levels of CD25 compared to intrathymic transfer of TCR-HA+ cells, 
which will be discussed in more detail later. 
 
Figure 8: Polyclonal CD25+ Foxp3- and CD25- Foxp3- GITR+ contain precursor cells 
to mature Foxp3+ Treg. 
a Gating strategy for sorting of the injected subsets. Numbers indicate percentage of 
cells within the respective gate b Subsets depicted above contour plots were sorted from 
WT CD45.1 mice and intrathymically transferred into WT CD45.2 recipients (numbers in 
brackets depict number of transferred cells). Analysis was performed six days later. 
Numbers in the plots (gated on CD4+ CD8- CD45.1+) indicate percentage of Foxp3+ cells. 
Plots shown are representative pictures of one experiment with 2-3 mice per group. 
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In conclusion, both TCR-transgenic and polyclonal intrathymic transfer experiments 
strongly suggest a precursor-progeny relationship between CD25- Foxp3- GITR+, 
CD25+ Foxp3- and mature CD25+ Foxp3+ Treg, and show that the latter two subsets 
can develop to Foxp3+ Treg independent of further TCR-stimulation. 
 
 
5.3 TREG INDUCTION AFTER INTRATHYMIC TRANSFER OF NAÏVE CD4+ SPS 
5.3.1 INTRATHYMIC TRANSFER INTO AIRE-HA MICE 
Work from several groups has suggested that Tregs can be induced by thymic agonist 
ligands. However, it has been argued that this process may not represent de novo 
differentiation, but rather selective survival of committed precursors [59]. Beside that, it 
has not been clearly shown so far at which stage of thymocyte development cells 
commit to the Treg lineage, with one publication arguing for the double positive (DP) 
stage [76]. Another model suggested that already at the DN stage developing 
thymocytes might be trans-conditioned for development along the Treg lineage [90]. 
Based on our findings of a precursor-progeny relationship in TCR-HA+ CD4+ SPs of 
AIRE-HA × TCR-HA mice we wanted to elucidate whether late stage induction to the 
Treg lineage is possible. For this reason, intrathymic transfer of naïve CD4+ SPs from 
TCR-HA+ RAG2-/- Foxp3gfp CD45.1 mice into either AIRE-HA (CD45.2) or WT (CD45.2) 
recipients was performed (Figure 9). By using this transfer method the fate of naïve, 
truly antigen unexperienced CD4+ SPs at a defined developmental stage can be 
followed in their natural thymic environment, either in the presence or absence of 
cognate antigen. Note that usage of endogenously rearranged TCR α-chains was 
excluded by using mice on a RAG2-/- background. 
 
 
 
 
 
 
 
 
 
 
Figure 9: Design of congenic 
intrathymic transfer experiments 
5x105 (unless stated otherwise) CD4+ 
SPs or CD4+ peripheral T cells were 
isolated from TCR-HA+ RAG2-/- 
Foxp3gfp CD45.1 donor animals and 
injected into the thymus of either WT or 
AIRE-HA recipients (CD45.2). During 
analysis, injected cells were identified 
via expression of CD45.1 
 
 
Recipient mice were killed at day 1 to day 8 after intrathymic transfer and the injected 
cells were examined for CD25 and Foxp3 expression. Strikingly, in AIRE-HA but not in 
WT recipients Foxp3 induction was observed 3 to 4 days after transfer, which definitely 
proves that Treg induction can happen after encounter of cognate antigen at the single 
positive stage of thymocyte development (Figure 10a). 
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 Comprehensive analysis of recipients for each day revealed interesting details. In WT 
recipients, for each time-point analyzed essentially all of the injected cells stayed naïve 
(CD25- Foxp3-), arguing against the presence of any committed precursors in the 
transferred CD4+ SP population.  
 
 Figure 10: Induction of Foxp3+ Treg at the CD4+ SP stage is possible. 
5×105 TCR-HA+ RAG2-/- CD4+ SPs were intrathymically transferred into AIRE-HA and WT recipients 
followed by analysis for CD25 and Foxp3 expression on day 1-8 after transfer. a Representative 
contour plots of transferred cells (CD4+ CD8- CD45.1+) at the indicated time points. Numbers indicate 
mean percentages (n=3-5) of cells in the respective gate. b Emergence of CD25+ Foxp3+ cells in 
AIRE-HA recipients at the indicated time points. c Percentages of CD25+ Foxp3+ and CD25- Foxp3+ 
cells at the indicated time points. Note the selective increase of CD25- Foxp3+ cells at day 3 to day 5. 
 
 
 
 
 
 
 
In AIRE-HA recipients most of the cells (91.1 +/- 1.9%) became activated in terms of 
CD25 upregulation as early as 12 hours after injection. Until day 3 the ratio between 
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CD25- Foxp3- and CD25+ Foxp3- cells moved gradually to an equal distribution 
(55.4 +/- 4.8% for CD25- Foxp3- and 39.6 +/- 7.4% for CD25+ Foxp3- cells), which is also 
seen in AIRE-HA × TCR-HA mice (compare Figure 3). Due to the obtained cell 
numbers at day 1 and day 3 (Figure 11) the CD25+ cells are not likely to undergo 
apoptosis, but rather lose CD25 expression again to give rise to the CD25- population. 
The percentage of Foxp3+ cells in AIRE-HA recipients increased until day 5 (11.7 +/- 
1.5%), then remaining constant at a slightly lower level (Figure 10b). Of note, we 
observed that for day 3 to day 5 after transfer a high proportion of Foxp3+ cells showed 
no or only intermediate CD25 expression (Figure 10c), suggesting that CD25 
upregulation (confering IL-2 responsiveness) is not a prerequisite for Foxp3 induction 
[68]. 
Concerning the number of recovered cells, in WT recipients a gradual reduction down 
to 1000 injected cells was observed, consistent with the idea that the transferred 
thymocytes continue to mature and finally leave the thymus after four to five days [91]. 
For AIRE-HA recipients even less cells than in WT recipients were recovered at early 
time-points, possibly indicating negative selection of TCR-HA+ cells in the antigen 
expressing environment. From day three on the number of recovered cells started to 
increase, then decreased again until the end of the analyzed time period (Figure 11a). 
Of note, even after 14 days 500-2000 cells could be detected (data not shown), 
indicating that antigen exposure prolongs the average residence time of developing 
CD4+ SPs. Alternatively, cells could reimmigrate to the thymus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Analysis of cell count and proliferation after intrathymic transfer of naïve 
TCR-HA+ RAG2-/- CD4+ SPs into AIRE-HA mice. 
a Absolute number of recovered cells after intrathymic transfer at the indicated time points for 
AIRE-HA (black squares) and WT (open squares) recipients (n=3-5). Note the steady decrease 
for WT recipients, while in AIRE-HA recipients cell numbers increase at day 3. b Induction of 
proliferation after intrathymic antigen encounter. Representative pkh26 profile for the indicated 
subsets of transferred cells (gated on CD4+ CD8- CD45.1+) in AIRE-HA recipients, with CD25+ 
Foxp3+ cells dividing least. 
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 To analyze the proliferative history of the recovered cells, pkh26 labeling experiments 
were performed. pkh26 is a liphophilic compound which is incooperated into the cell 
membrane and diluted with each cell division. Although Carboxy Fluoroscein 
Succinimidyl Ester (CFSE) would have been superior to pkh26 in terms of signal 
sharpness, CFSE could not be used because its signal would have been in the same 
fluorescence channel as the GFP signal of FoxpGFP. 
After intrathymic transfer of pkh26 labelled cells no reduction of the fluorescence signal 
was observed at day one and two (data not shown), while for the following days the 
pkh26 signal steadily decreased, indicative of continuous proliferation. Analysis of 
subsets revealed that at all time-points CD25+ Foxp3+ cells had divided least (Figure 
11b).  
In WT recipients all of the injected cells remained pkh26 high, only losing roughly 10% 
of their initial fluorescence intensity which is the expected stochastic loss according to 
the manufacturer. 
 
 
5.3.2 EFFECTS OF INTRACLONAL COMPETITION 
Having shown that induction of Treg can take place at the CD4+ SP stage we asked 
how this process would be affected by intraclonal competition, i.e. the competition for 
agonist ligands. Therefore we performed intrathymic transfer of naïve TCR-HA+ RAG2-/- 
CD4+ SPs into AIRE-HA × TCR-HA mice. Analysis 6 days after transfer revealed the 
unexpected findings that in terms of percentage more Foxp3+ cells developed, but 
according to the pkh26 signal for all subsets less proliferation than in AIRE-HA 
recipients was observed (Figure 12). The latter was reflected by the reduced number of 
recovered cells. 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Decreased proliferation after intrathymic transfer of TCR-HA+ RAG2-/- CD4+ SPs 
into AIRE-HA × TCR-HA recipients 
a Representative plots for transferred cells (CD4+ CD8- CD45.1+) at day 6 after transfer. Values 
indicate mean percentage (n=6-8) of cells in the respective gate. The pkh26 profile shows 
reduced proliferation of all subsets compared to AIRE-HA recipients (see Figure 11b). b Statistics 
for the percentage of Foxp3+ cells in AIRE-HA and AIRE-HA × TCR-HA recipients at day 6 after 
intrathymic transfer. 
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Figure 13: Analysis of cell count and proliferation within a 5-fold dilution series of 
transferred naïve TCR-HA+ RAG2-/- CD4+ SPs into AIRE-HA mice. 
a Intraclonal competition affects both the proliferation and the efficiency of Treg induction. 
Representative plots of transferred cells (CD4+ CD8- CD45.1+) after five days. Injected cell 
numbers are indicated above, pkh26 profile of the indicated subsets below with the same color 
code used throughout this work. Both recovered cell numbers and percentages of Foxp3+ cells 
decreased continuously from 2.5×106 down to 0.02×106 injected cells, as statistically shown in the 
bar diagrams (n=3). Note that the lower percentage of Foxp3+ cells for intrathymic transfer of 
0.5×106 cells as compared to Figure 10 might be due to slightly reduced fitness of cells because 
of the pkh26 labelling. b Statistics for the percentage of injected cells not having divided at all and 
having divided at least 10 times. 
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 Due to the results described above and the observation that after intrathymic transfer 
the emerging Foxp3+ cells have divided less than the other subsets we asked whether 
proliferation and differentiation are opposing processes within our system. We 
hypothesized that transferring a high number of cells would result in competition for 
both available growth factor and antigen binding sites, consequently reducing 
proliferation. To examine the effects of intraclonal competition in more detail, 2.5×106, 
0.5×106, 1×105 and 0.2×105 pkh26 labelled cells were injected into AIRE-HA mice. 
Recipient mice were analyzed 5 days after intrathymic transfer. The more cells we 
injected the more were recovered, roughly reflecting the initial five-fold dilution series. 
But strikingly, there was a strong correlation between the number of injected cells and 
the percentage of Foxp3+ cells, with hardly any Foxp3 expression following injection of 
2×104 cells (Figure 13a). 
Analysis of the pkh26 profile revealed that at a higher number of injected cells less 
proliferation took place (Figure 13b). Losing the pkh26 signal completely corresponds 
to at least 10 cell divisions according to the manufacturer, implying that these cells 
underwent extensive cycling. Furthermore, we observed again that CD25+ Foxp3+ cells 
were cycling less than the other subsets. 
These results suggest a model in which proliferation and differentiation of Treg 
precursors are opposing processes and will be discussed in more detail later.  
 
 
5.4 DEVELOPMENTAL PLASTICITY WITHIN CD4+ SPS 
5.4.1 INTRATHYMIC INJECTION OF CD69+ AND CD69- CD4+ SPS 
Another issue we wanted to clarify is whether induction of natural Tregs can only 
happen at certain developmental stages, for example at the early CD4+ SP stage. This 
hypothesis was based on a more detailed examination or AIRE-HA × TCR-HA mice 
showing that most of the TCR-HA+ cells reside within the CD4+ CD8int compartment.  
Thus we asked whether immature CD4+ SPs have a higher capacity to develop into 
Foxp3+ cells than more mature thymocytes. As expression of a transgenic TCR is 
known to slightly alter the thymocyte distribution in terms of maturity and percentage 
[55], we stained both WT and TCR-HA+ RAG2-/- Foxp3gfp animals for CD69 and CD24. 
In the CD4+ SP compartment of TCR-HA+ RAG2-/- Foxp3gfp mice we observed biphasic 
expression of CD69, which was more pronounced than in the CD4+ CD8- compartment 
of BALB/c animals. Costaining for CD24 showed that CD4+ CD69- SPs expressed 
lower levels of CD24 than CD4+ CD69+ cells ( a), confirming that CD69+ CD4+ 
SPs can be regarded immature and CD69- CD4+ SPs mature [6]. 
Figure 14
Figure 14
Intrathymic transfer of these two subsets into AIRE-HA and AIRE-HA × TCR-HA 
recipients revealed that a 2-3 fold higher percentage of CD69+ than CD69- CD4+ SPs 
developed into Treg ( b). In terms of recovered cell number we could not 
detect any significant differences. 
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Additionally, we injected peripheral CD4+ cells, which also developed to Foxp3+ cells in 
AIRE-HA recipients. This demonstrates that conversion to Treg is still possible even in 
this mature state of T cell development. Interestingly, in AIRE-HA × TCR-HA recipients 
we could rarely detect any of the injected peripheral cells (only 50-100 cells per 
mouse). 
 
 
 
 Figure 14: Intrathymic transfer of naïve TCR-HA+ RAG2-/- CD69+ CD4+ and CD69- CD4+ SPs 
into AIRE-HA or AIRE-HA × TCR-HA recipients 
a Costaining for CD69 and CD24 of CD4+ SPs in TCR-HA+ RAG2-/- animals, showing that there 
are two populations in terms of CD69 expression, with lower CD24 levels in the CD69- population. 
c and b Intrathymic transfer of mature und immature CD4+ SPs shows different efficacy of Treg 
induction. Percentages of Foxp3+ cells after intrathymic transfer into AIRE-HA (b) and AIRE-HA × 
TCR-HA (c) recipients (n=3-4) is shown. Note that in AIRE-HA × TCR-HA recipients peripheral 
cells could not be detected after intrathymic transfer. 
 
 
 
 
 
 
 
 
5.5 ROLE OF ANTIGEN PRESENTATION BY HEMATOPOIETIC CELLS FOR TREG 
INDUCTION AT THE CD4+ SP STAGE 
5.5.1 INTRATHYMIC TRANSFER AND THE INFLUENCE OF ANTIGEN EXPRESSION LEVELS 
Although published for the steady state situation of AIRE-HA × TCR-HA mice [58] we 
wanted to definitely rule out that antigen presentation by hematopoietic cells is 
necessary for Treg induction at the CD4+ SP stage. Due to the fact that on BALB/c 
background no MHC class II knockout mice are available and CIITA knockout mice still 
show some basal MHC class II expression [92], we had to use a different strategy 
involving bone marrow chimeras.  
For this purpose AIRE-HA+/- F1 (BALB/c × C57Bl/6) mice were bred, which are 
supposed to express the MHC class II haplotypes I-Ed and I-Ab. Within these mice the 
amount of I-Ed molecules on the surface of antigen presenting cells is expected to 
decrease more than only 50% because the available MHC class II chains can pair with 
each other at unknown efficiency. To measure antigen presentation levels, we co-
cultivated splenic HA-pulsed APCs from F1 (H-2b/d) and BALB/c (H-2d/d) animals with 
A5 hybridoma cells expressing the TCR-HA. TCR triggering of these hybridoma cells 
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 leads to costimulation independent expression of a GFP reporter construct, thereby 
directly measuring the strength of TCR-signal. Analysis of GFP expression over a 
range of HA-peptide concentrations revealed a roughly 25-fold difference between 
BALB/c and F1 APCs (data not shown). 
Subsequent intrathymic transfer experiments showed that in comparison to AIRE-HA 
mice on BALB/c background in AIRE-HA F1 recipients a 2-3 fold higher percentage of 
injected cells developed to Foxp3+ Treg (Figure 15a). However, as the total number of 
recovered cells in AIRE-HA F1 recipients was lower, the absolute count of Foxp3+ Treg 
was roughly equal in both AIRE-HA and AIRE-HA F1 recipients ( b). These 
observations indicate that the reduced amount of agonist ligand in F1 (H-2b/d) thymi 
affects proliferation of antigen-specific thymocytes, while differentiation to Treg as such 
remains intact. 
Figure 15
Figure 15: Intrathymic transfer of naïve TCR-HA+ RAG2-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 /- CD4+ SPs into 
AIRE-HA F1 (BALB/c × C57Bl/6) recipients 
a Decreased levels of antigen presentation increase the relative rate of Treg 
induction. Representative plots of transferred cells (CD4+ CD8- CD45.1+) after five 
days are shown. Haplotype of MHC class II expression in the respective recipient 
animal is shown above dot plot. 
b Absolute numbers of Foxp3+ cells after intrathymic transfer into the indicated 
recipient animals (left plot), and absolute number of donor recovered cells (right 
plot). Note the significant increase for AIRE-HCO recipients. 
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To extend this hypothesis, intrathymic transfer of TCR-HA+ cells into AIRE-HCO 
recipients was performed. AIRE-HCO mice have been generated in our lab recently 
(see section 5.6) and express much higher levels of antigen than AIRE-HA mice, as 
quantified by stimulation of A5 hybridoma cells (data not shown). Analysis of injected 
cells revealed massive proliferation, with 1% of injected cells developing to Foxp3+ 
Treg (Figure 15a and b). These observations further emphasize the role of antigen 
level and will be discussed in more detail later. 
 
 
5.5.2 FOXP3 INDUCTION AFTER INTRATHYMIC TRANSFER IS INDEPENDENT OF ANTIGEN 
PRESENTATION BY HEMATOPOIETIC CELLS 
To address the initial question whether antigen presentation by hematopoietic cells 
plays a role for Treg induction at the CD4+ SP stage a series of bone marrow chimeras 
was generated using AIRE-HA F1 (BALB/c × C57Bl/6) animals. These mice were 
lethally irradiated and reconstituted with either BALB/c bone marrow (expressing I-Ad 
and I-Ed MHC class II molecules) or C57Bl/6 bone marrow (expressing only I-Ab class II 
molecules). As the TCR-HA recognizes hemagglutinin only in the context of I-Ed [93], in 
AIRE-HA F1 animals reconstituted with C57Bl/6 bone marrow (further on referred to as 
F1 AIRE-HABM H-2b/b) only radioresistant epithelial cells, but not hematopoietic cells were 
able to present the cognate antigen. 
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F gure 16: Intrathymic transfer of 
naïve TCR-HA+ RAG2-/- CD4+ SPs 
into AIRE-HA F1 (BALB/c × 
C57Bl/6) bone marrow chimeras 
a Design of intratyhmic transfer 
experiments. Note that in F1 AIRE-
HABM H-2b/b animals the TCR-HA 
cannot recognize antigen on 
hematopoietic cells because of its 
restriction to I-Ed. 
b e of Foxp3+ cells after 
intrathymic transfer into the indicated 
bone marrow chimeras after five 
days.  Note that absence of antigen 
presentation on haematopoietic cells 
does not disturb Treg induction. 
Representative plots for three 
recipient mice are shown. 
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 Six weeks after reconstitution the bone marrow chimeras were intrathymically injected 
with 5×105 sorted CD4+ SPs from TCR-HA+ RAG2-/- Foxp3gfp CD45.1+ mice and 
analyzed six days later. Development of CD25+ Foxp3+ cells was not disturbed, and as 
already noted for AIRE-HA F1 mice, both in F1 AIRE-HABM H-2b/b and F1 
AIRE-HABM H-2d/d recipients 20-30% of injected cells developed to Foxp3+ Treg (
b). Therefore, cross-presentation of antigen by hematopoietic cells is not essential 
for the conversion of CD4+ SPs to Treg. 
Figure 
16
 
 
5.6 VALIDATION WITH ANOTHER TCR TRANSGENIC MODEL 
To formally exclude any potential “bias” of the TCR-HA towards differentiation to 
Foxp3+ Tregs we repeated some of the transfer experiments with the DO11.10 TCR 
transgenic system which recognizes amino acids 323-339 of Ovalbumin (OVA) in the 
context of I-Ed. As recipients we used AIRE-HCO mice recently generated in our lab, 
which express a fusion protein of hemagglutinin, C-reactive protein and ovalbumin 
under control of the Aire promotor. The phenotype of double transgenic AIRE-HCO × 
DO11.10 mice has been published previously [58]. 
Intrathymic transfer of CD4+ SPs from DO11.10+ RAG2-/- Foxp3gfp CD45.1+ mice into 
AIRE-HCO recipients essentially phenocopied the results obtained for the TCR-HA. At 
early time-points upregulation of CD25 was observed, while after 3-4 days Foxp3+ cells 
appeared (Figure 17), with around 10% Foxp3+ cells after 8 days.  
These results, in combination with the data shown so far, unequivocally show that 
naïve, antigen unexperienced CD4+ SPs can develop into CD25+ Foxp3+ Tregs after 
encountering their cognate antigen within the thymic medulla. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: Intrathymic transfer of naïve DO11.10+ CD4+ SPs into AIRE-HCO mice resembles 
the results obtained with the TCR-HA. 
Naive CD4+ SPs from DO11.10+ RAG-/- Foxp3gfp were transferred to AIRE-HCO recipients, 
contour plots are gated on transferred cells. Time-point after transfer is shown above, numbers in 
the plots indicate percentage of cells in the respective gate. 
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5.7 IN VITRO EXPERIMENTS 
5.7.1 IN VITRO CULTURE OF TCR-HA+ SUBSETS FROM AIRE-HA × TCR-HA MICE 
The in vivo transfer experiments (section 5.2) together with the analysis of maturation 
and activation markers (section 5.1.2) suggest that there is a direct developmental 
relationship between CD25- Foxp3-, CD25+ Foxp3- and CD25+ Foxp3+ cells in double 
transgenic AIRE-HA × TCR-HA mice. To more precisely address the role of interacting 
cell types and the required stimuli at each developmental step, in vitro experiments 
were done. As a first approach, the same TCR-HA+ subsets as in our in vivo 
experiments were sorted from AIRE-HA × TCR-HA mice (CD25- Foxp3- GITR-, CD25- 
Foxp3- GITR+ and CD25+ Foxp3- cells). For control purposes naïve CD4+ SPs from 
TCR-HA+ RAG2-/- Foxp3GFP mice were included. 
After cultivation under various conditions, several remarkable observations were made. 
Most interestingly, stimulation of CD25+ Foxp3- cells without any further TCR-stimulus 
but only with IL-2 resulted in expression of Foxp3 by 44.7% of cells after three days. 
This effect was seen to a lesser extent for CD25- Foxp3- GITR+ cells (30.5%), but not 
for CD25- Foxp3- GITR- (4.3%) and naïve TCR-HA+ RAG2-/- cells (Figure 18a). 
 Figure 18: TCR-independent development of CD25- Foxp3- GITR+ and CD25+ Foxp3- to Foxp3+ Treg 
a Flow cytometric analysis of naïve CD4+ SPs from TCR-HA RAG2-/- mice or sorted subsets from 
AIRE-HA × TCR-HA mice after three days of culture in the presence of 100 Units/ml IL-2. b Statistical 
analysis of Foxp3 expression after cultivation of the indicated thymocyte subsets for three days with 
AIRE-HA mTEC and IL-2 (black bars), AIRE-HA DCs and IL-2 (open bars) and IL-2 alone (dark grey 
bars).  
c Statistical analysis of Foxp3 expression after five days. AIRE-HA mTECs and IL-2 (black bars), AIRE-
HA DCs and IL-2 (open bars), splenic APCs with 5 µg/ml HA-peptide and IL-2 (light grey bars), IL-2 
alone (dark grey bars). Note that for CD25- Foxp3- GITR- cells Foxp3+ expression is hardly induced by 
splenic APCs, which is not the case for CD25- Foxp3- GITR+ and CD25+ Foxp3- cells. (N.D. not done) 
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 Therefore, the CD25+ Foxp3- subset contains a high proportion of direct precursors for 
mature Foxp3+ Treg. Very recently, similar experiments with polyclonal cells have been 
done by another group, allowing the same conclusion [94] which emphasizes that our 
data indeed mimics the polyclonal system. However, our experiments provide 
additional insights into these previously uncharacterized processes preceding Foxp3 
induction. 
Both the CD25+ Foxp3- and the CD25- Foxp3- GITR+ subsets contain cells which 
continue to develop to Foxp3 only in the presence of IL-2, but in either case the 
presence of a TCR stimulus enhanced this process (Figure 18b and c) up to twofold. 
Strikingly, coculture with AIRE-HA mTECs or thymic AIRE-HA DCs allowed Foxp3 
induction in CD25- Foxp3- GITR- cells, which was only very inefficiently the case for 
irradiated splenic APCs pulsed with 5 µg/ml HA-peptide. As in this experiment no 
titration of the agonist-peptide was performed, for the splenic APCs dose-dependent 
effects can not be ruled out, but still one could hypothesize that for the initial step of the 
Treg developmental program the interacting cell type is crucial, while after that TCR 
stimuli provided by any APC drive Foxp3 induction. 
Of note, under the experimental conditions used there seems to be an upper limit for 
the conversion rate of CD25+ Foxp3- cells to Foxp3+ Treg, because in the presence of 
mTECs the percentage of Foxp3+ cells on day 3 equals the result after 5 days. The 
same percentage of conversion, roughly 60%, was reached by CD25- Foxp3- GITR+ 
cells after 5 days as well. However, one cannot excluded that under different 
conditions, for example an higher ratio of mTECs to thymocytes, all CD25- Foxp3+ 
would have the ability to upregulate Foxp3. 
As an additional interesting facet, CD25- Foxp3- GITR- cells gave rise to more Foxp3+ 
cells than naïve CD4+ SPs from TCR-HA+ RAG2-/- mice (Figure 18c), which suggests 
that the former population does not represent truly naïve thymocytes, but might include 
already activated cells. 
In conclusion, these results substantiate our in vivo experiments and argue for 
sequential developmental steps in the order CD25- Foxp3- GITR- → CD25- Foxp3- 
GITR+ → CD25+ Foxp3- → mature CD25+ Foxp3+ Treg, which will be elaborated in 
more detail in the discussion. 
 
 
5.7.2 IN VITRO CULTURE OF NAÏVE TCR-HA+ CD4+ SPS WITH MTECS AND DCS 
Studying the efficiency of Treg induction after intrathymic transfer is complicated by the 
fact that thymic egress cannot be controlled. Furthermore, elucidating mechanistic 
details is difficult as the thymic microenvironment after injection is unknown. Therefore, 
we asked whether it would be possible to mimic the in vivo situation of natural Treg 
induction by simply cultivating naïve CD4+ thymocytes with either mTECs or thymic 
DCs in vitro. This would allow following the contribution of the antigen presenting cells 
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in a defined microenvironment, in which for example individual cytokines can be 
neutralized or exogenously added.  
In a first approach we sorted mTECs (defined as CD45- Ly51- EpCAM+) from AIRE-HA 
mice and cultivated them with CD4+ SPs from TCR-HA+ RAG2-/- Foxp3gfp mice in the 
presence of IL-2 as a survival factor. Indeed, mTECs were capable to convert CD4+ 
SPs to CD25+ Foxp3+ regulatory T cells after 5 days of in vitro culture (Figure 19a). 
Analysis of the kinetics of this process roughly equalled our in vivo results (data not 
shown). 
 
Figure 19: mTEC and thymic DC can support differentiation of Treg in vitro 
a CD4+ SPs were cultivated with AIRE-HA mTECs for five days. One representative plot of three 
independent experiments is shown. Percentage of Foxp3+ cells is indicated below gate. b Indicated T 
cell subsets were cultivated with AIRE-HA mTECs for five days. Note the correlation with our in vivo 
results (Figure 14) in that the most immature CD4+ SPs yield the highest percentage of Foxp3+ cells. 
CD4+ T(x), peripheral CD4+ T cells from a thymectomized donor mouse. c and d Percentage (c) and 
absolute numbers of Foxp3+ cells (d) after 5 days of in vitro culture of CD4+ SPs with WT mTECs and 
DCs at the indicated concentration of HA-peptide. e and f Percentage of Foxp3+ cells with or without 
TGF-β inhibition (monclonal anti-TGF-β antibody and the inhibitor SB-431542) after five days of in vitro 
culture of CD4+ SPs with WT mTECs (e) or WT DCs (f) and the indicated concentration of HA-peptide. 
Note the significant decrease in the percentage of Foxp3+ cells for both APC types, but the dependence 
on the concentration of agonist peptide.  
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We asked next whether our in vivo results showing an inverse relationship between T 
cell maturity and their ability to differentiate to Treg could be reproduced in vitro. For 
this purpose, we sorted CD69+ CD4+ SPs, CD69- CD4+ SPs and peripheral CD4+ T 
cells from TCR-HA+ RAG2-/- Foxp3gfp mice. After cultivation for 5 days with AIRE-HA 
mTECs, CD69+ CD4+ SPs yielded the highest percentage of Foxp3+ Treg, while both 
CD4+ CD69- thymocytes and peripheral CD4+ T cells were less competent (Figure 19b). 
Furthermore, we used peripheral CD4+ T cells from thymectomized donor mice, 
thereby excluding the presence of recent thymic emigrants in our starting population. In 
line with our hypothesis that during progressive maturation T cells lose their plasticity to 
develop to Treg, peripheral T cells from thymectomized mice showed even lower 
efficacy for Treg conversion. 
To gain additional insight into the relevance of both the antigen presenting cell type and 
the antigen level, co-culture of WT mTECs (CD45- Ly51- EpCAM+) and thymic WT DCs 
(defined as CD45+ CD11c+) with CD4+ SPs in the presence of titrated amounts of HA-
peptide was performed. Unexpectedly, both mTECs and DCs proved to induce Foxp3 
expression efficiently, but at markedly different antigen concentrations ( c). 
While mTECs yielded 20-30% of Foxp3+ cells at peptide concentrations higher than 
0.2 µg/ml, thymic DCs did so at concentrations below 0.2 µg/ml. Interestingly, while the 
maximum percentage of Foxp3+ cells was similar for both APC types, in terms of 
absolute numbers, mTECs were superior to DCs in their ability for Treg induction 
(Figure 19d). 
Figure 19
Figure 
19
 
 
5.7.3 TGF-β DEPENDENCE IN VITRO 
As mentioned in the introduction, it was widely accepted during the last years that 
transforming growth factor-β (TGF-β) is only involved in the peripheral generation of 
Treg, but not in their thymic development. A recent publication challenged this 
widespread notion [63]. 
Therefore we sought to determine the importance of (TGF-β) in our in vitro system. For 
this purpose we used both an neutralizing TGF-β antibody and an inhibitor of TGF-β 
signaling, namely SB431542 [80]. The latter compound works by inhibiting Activin-
receptor like kinases (ALK) 4, 5 and 7, whereby ALK-5 is the TGF-β receptor 1 which is 
required for the functional TGF-β receptor complex. Prior titration has shown that the 
neutralizing antibody was efficient at 10 µg/ml and SB-431542 at a concentration of 
3 µM (data not shown). 
Inhibiting TGF-β resulted in a slight increase of the total cell numbers in each well, 
which is due to the known antiproliferative effects of TGF-β [95]. Beside that, TGF-β 
inhibition had a strong effect on both mTEC- and DC-mediated Treg induction (
e and f, respectively). Of note, inhibition was not complete especially for mTECs at 
lower peptide concentrations, while for DCs at all concentrations the reduction in 
Foxp3+ cells was at least 5-fold. 
6 DISCUSSION 
6.1 PRECURSOR-PROGENY RELATIONSHIP BETWEEN CD25+FOXP3- THYMOCYTES 
AND CD25+FOXP3+ REGULATORY T CELLS 
Regulatory T cells (Treg) are indispensable for prevention of autoimmune disease, but 
still the processes underlying their thymic development remain enigmatic. By using a 
T cell receptor (TCR) transgenic system which allows tracking the fate of single T cells 
with known TCR specificity, we identified CD25+ Foxp3- thymocytes as direct 
precursors of mature CD25+ Foxp3+ Treg. 
 
 
6.1.1 CD25+ FOXP3- THYMOCYTES CONTINUE TO DEVELOP TO CD25+ FOXP3+ TREG BOTH 
IN VITRO AND IN VIVO 
After intrathymic transfer of the sorted TCR-HA+ subsets found in the CD4+ SP 
compartment of AIRE-HA × TCR-HA mice into AIRE-HA recipients we observed that 
both GITR- and GITR+ CD25- Foxp3- as well as CD25+ Foxp3- cells gave rise to Foxp3+ 
Treg, but the latter at the highest frequency. Thus, in vivo after encountering their 
cognate antigen all these thymocyte subsets are able to express Foxp3, but the CD25+ 
Foxp3- subset is enriched for cells doing so. Importantly, after transfer into WT mice 
CD25+ Foxp3- and GITR+ CD25- Foxp3- cells developed to Foxp3+ cells as well, albeit 
at a lower frequency than in AIRE-HA mice. 
In vitro, we could observe that in the presence of IL-2, cultivation of TCR-HA+ CD25- 
Foxp3- GITR+ and CD25+ Foxp3- subsets from AIRE-HA × TCR-HA mice led to Foxp3 
expression in nearly 50% of these cells. The same tendency, albeit to a lesser extent 
was monitored after cultivation with IL-15 (data not shown). 
Collectively, these findings prove unambiguously that CD25+ Foxp3- thymocytes do not 
represent a developmental dead end, but instead contain direct precursors of Foxp3+ 
Treg. Cells at the CD25+ Foxp3- and CD25- Foxp3- GITR+ stage do not need any 
further TCR stimulus, but just cytokine signalling to upregulate Foxp3 as shown by our 
in vitro experiments. This conclusion is underscored by our in vivo transfer 
experiments, where in WT recipients a fraction of injected TCR transgenic CD25+ 
Foxp3- and CD25- Foxp3- GITR+, but not GITR- cells are able to upregulate Foxp3. 
However, the frequency of developing Foxp3+ Treg was higher in vivo after intrathymic 
transfer into AIRE-HA recipients and in vitro in the presence of antigen presenting cells. 
These observations emphasize that a microenvironment providing TCR stimulus and 
appropriate cytokine milieu is the most efficient differentiation environment. 
Our data is partially mirrored by a very recent publication showing for the polyclonal 
system that CD25+ Foxp3- thymocytes are Treg precursor cells [94]. The authors 
propose a “two-step process”, with TCR-stimuli conferring cytokine responsiveness to 
developing thymocytes, which then undergo cytokine dependent Foxp3 upregulation. 
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 Our finding that the presence of antigen increases differentiation efficiency argues 
rather for an integration of both TCR and cytokine signals at all developmental stages. 
Given the fact that in vitro nearly 50% of CD25+ Foxp3- cells are capable of Foxp3 
upregulation, while in vivo even in the presence of antigen only around 20% do so, a 
bottleneck restraining the development of these cells must exist. Several potential 
explanations could be envisioned, namely the limited availability of cytokines or other 
soluble factors, or the limited accessibility of rare antigen presenting cells such as 
mTECs. 
Of note, in vivo around one third of transferred CD25+ Foxp3- cells lost expression of 
CD25 again. As the percentage of these cells roughly equals the difference between 
our observed in vitro and in vivo conversion rates, it could be imagined that these 
CD25- cells represent the “outcompeted” population and will be cleared by negative 
selection.  
 
 
 
6.2 REGULATORY T CELL INDUCTION AT THE CD4+ SP STAGE 
To follow the fate of truly naive CD4+ SPs after encounter of cognate antigen in the 
thymus, intrathymic transfer experiments were performed. In contrast to work arguing 
for Treg induction at the DP stage [76, 96] we could show for two different TCR 
transgenic systems that in the presence of agonist ligand development to Foxp3+ Treg 
at the CD4+ SP stage is possible. Although this does not exclude that events prior to 
the CD4+ SP stage initiate Treg development in some cells [90], our observations 
definitely show that Treg induction can happen completely dissociated from lineage 
commitment and positive selection.  
 
 
6.2.1 DEVELOPMENT OF FOXP3+ TREG AFTER INTRATHYMIC TRANSFER 
Intrathymic transfer of TCR transgenic CD4+ SPs yielded efficient development to Treg 
only in antigen expressing recipients, but not in WT mice, where all of the transferred 
cells stayed phenotypically naïve. This emphasizes the role of TCR interactions with 
peptide-MHC class II complexes, but does not formally exclude a stochastic model of 
Treg development as proposed by the Mathis group [59]. However, if stochastic 
priming of the Treg program at earlier developmental stages occurs, for example in the 
cortex, it is not sufficient to induce Foxp3 expression without additional agonist ligand 
signals. 
By analyzing recipient mice each day after transfer we could delineate a series of 
events preceding Foxp3 induction. At early timepoints rapid upregulation of CD25 and 
GITR was observed, while the functional importance of these events remains unclear. 
CD25 expression has already been shown to be Foxp3 independent [51], and is not 
likely to fulfill a crucial role in terms of IL-2 signaling, as our lab [68] and others [67] 
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have shown that IL-2 is not essential for thymic Treg development. However, given that 
in vitro CD25+ Foxp3- cells continue to develop to Foxp3+ Treg in the presence of IL-2 
as well as IL-15, cytokine responsiveness to common γ-chain cytokines might be an 
important criterion at this stage. This hypothesis is emphasized by the fact that both 
IL-2Rβ knockout mice [97] and IL-2/IL-15 double knockout mice [70] lack Foxp3+ Treg. 
Since in the polyclonal system IL-2 deficiency results in a slight decrease in Treg 
numbers, there might be some redundancy, with a certain level of cytokine signaling 
being critical instead of a single cytokine. Support for this idea is provided by the fact 
that a CD4+ T cell specific deletion of STAT5, which is required to transduce signals 
from the common γ-chain cytokine receptor, strongly reduces the number of mature 
Foxp3+ Treg [70], while a constitutively active form of STAT5 is sufficient to drive Treg 
induction [78]. 
On day two and three after intrathymic transfer, a fraction of CD25+ Foxp3- cells lose 
CD25 expression again. The first Foxp3+ cells appear at day three, which tend to 
express only intermediate levels of CD25. Until day 5, the number of CD25+ Foxp3+ 
cells increases steadily, accompanied by upregulation of CD25 within this population, 
as expected because of CD25 being a direct target gene of Foxp3 [49]. Interestingly, at 
the same time the percentage of CD25intFoxp3+ cells remain roughly constant. 
Although one cannot exclude that these cells leave the thymus as CD25- Foxp3+ cells, 
the kinetics of their appearance suggest that this CD25int Foxp3+ population represents 
an intermediate developmental step. 
 
 
6.2.2 PROLIFERATION OF TCR-HA+ CD4+ SP AFTER INTRATHYMIC TRANSFER 
After intrathymic transfer into AIRE-HA recipients extensive proliferation both within the 
CD25+ Foxp3- and CD25- Foxp3- subset was observed. Proliferation of CD4+ SPs has 
already been shown earlier [98], but the expansion of autoreactive T cells appears to 
be counterproductive at first sight. Even more complex, titration experiments and 
intrathymic transfer into AIRE-HA × TCR-HA recipients suggest that within the Treg 
precursor pool proliferation and differentiation are counteracting processes. 
However, given that not all CD25+ Foxp3- are capable of developing to Foxp3+ Treg 
both in vivo and in vitro one could envision a process in which the precursor pool 
expands to ensure development of a reasonable number of Treg. This idea is 
substantiated by the fact that in the steady state also polyclonal CD25+ Foxp3- 
thymocytes show more proliferation than conventional CD25- cells (according to KI67 
staining, data not shown), which argues against proliferation being an artifical 
phenomenon of TCR transgenic cells. Nevertheless, in WT mice only 1-3% of mTECs 
are thought to present one specific tissue restricted antigen [15], while in AIRE-HA 
mice HA is probably expressed by the majority of mTECs. The observed proliferative 
burst might be due to the abundance of HA, while for sparse antigens only modest 
proliferation might result. 
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 Another reasonable explanation for the observed cell cycling of Treg precursors might 
be the requirement for demethylation of the Foxp3 locus. It has been suggested 
recently that demethylation of CpG islets in a conserved region within the Foxp3 locus 
is crucial for sustaining Foxp3 expression [99], but it is not clear whether this is brought 
about by active demethylation processes. Thus, precursor cells committing to the Treg 
lineage might undergo a limited number of divisions accompanied by a lack of de novo 
methylation. 
An important issue is the long-term fate of the intrathymically transferred cells, as in the 
thymi of AIRE-HA recipients even after 14 days still 1000-3000 injected cells could be 
detected. However, it is known that on average CD4+ SPs spend 4-7 days in the 
medulla [91], which equals our observations after intrathymic transfer into WT mice. 
The prolonged persistence of TCR-HA+ cells in AIRE-HA mice might be due to 
upregulation of adhesion molecules following antigen encounter, as has been 
suggested earlier [100]. Since cells persisting after 14 days were mostly CD25- Foxp3- 
(data not shown), development along the Treg lineage does not occur for all TCR-HA+ 
cells, which leaves two possibilities: either they are deleted or escape to the periphery 
as autoreactive T cells, where they would be kept in check by simultaneously 
generated Treg. Evidently, we could not address this issue by analyzing the periphery 
of intrathymically injected mice because during the operation per se a certain number 
of naïve injected cells will already enter the bloodstream.  
However, both options might be true because in the thymus of AIRE-HA × TCR-HA a 
significant fraction of TCR-HA+ cells is deleted, while in the lymph nodes of these mice 
still TCR-HA+ cells exist which do not express CD25+ [58]. Furthermore, it has already 
been shown that within the polyclonal repertoire one TCR specificity can be found both 
within the Treg and the conventional T cell population, suggesting that Treg induction 
and escape of autoreactive T cells can indeed happen side by side [44]. 
 
 
6.2.3 EFFECT OF ANTIGEN PRESENTATION LEVELS 
After initial interpretations of Treg development hypothesizing that TCR affinity dictates 
the decision between negative selection and Treg induction it has been appreciated 
that this view is too simplistic [101]. However, within our intrathymic transfer system we 
found not the TCR affinity but the antigen level to influence both proliferation and 
differentiation of TCR-HA+ CD4+ SPs in a delicate way.  
A 25-fold reduction in antigen presentation levels led both to enhanced conversion and 
reduced proliferation. In line with these observations, intrathymic transfer of TCR-HA+ 
CD4+ SPs into AIRE-HCO mice (which express higher antigen levels than AIRE-HA 
mice) led to enormous proliferation of the transferred cells, with 1% of cells giving rise 
to Foxp3+ Treg. Importantly, in the steady state situation in AIRE-HCO × TCR-HA mice 
TCR-HA+ cells are deleted (data not shown). Putting these observations together, the 
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antigen level might not dictate the decision without other factors, but still influences the 
efficiency of Treg generation in an important way. 
 
 
6.2.4 DEVELOPMENTAL PLASTICITY  
Does Treg development require a specialized niche within the thymus which favors 
Foxp3 induction, or can Treg commitment only happen at a certain stage of thymocyte 
development? Several observations suggested convincingly that the thymic medulla 
provides such a niche. The autoimmune phenotype of TRAF6 (tumor necrosis factor 
receptor-associated factor 6) knockout mice is due to improper organization of the 
thymic medulla [102], and the absence of Foxp3+ Treg in neonatal mice has been 
ascribed to the absence of fully developed medullary islands [75]. 
However, our experimental data show that the developmental stage matters as well. 
After intrathymic transfer immature CD69+ CD4+ SPs gave rise to 3-4 fold more Foxp3+ 
Treg than CD69- CD4+ SPs. Since both subsets are expected to be localized in 
medullary regions, this implies that immature CD4+ SPs are more likely to differentiate 
to Treg after encountering peptide-MHC class II complexes. This observation supports 
a model in which the thymic medulla indeed plays the major role in Treg induction, but 
the likelihood of Treg development is influenced by the maturation stage of the 
CD4+ SP, i.e. cells just entering medullary regions have a higher capacity to develop 
along the Treg lineage. 
 
 
6.2.5 RECEPTOR SPECIFICITY, AFFINITY AND TCR SIGNALING 
Several studies have suggested that the Treg population contains a high frequency of 
self-reactive TCRs [44], which favors an agonist ligand-model of Treg induction. The 
notion of Treg TCRs being self-reactive was challenged by a recent publication arguing 
that a significant fraction of the Treg TCR repertoire recognizes non-self antigen [103]. 
This is not at odds with an agonist ligand model of thymic Treg development because 
peripheral mechanism might contribute to the Treg pool as has been demonstrated 
very elegantly by the von Boehmer lab [104]. 
However, the authors also claimed that several analyzed TCRs were found both in the 
Treg and conventional T cell population [103]. This would actually support a model 
whereby the same thymocyte expressing a certain TCR can differentiate either along 
the Treg lineage or escape to the periphery.  
In this context it is important to discuss that the affinity of a given TCR for a certain 
peptide MHC-class complex is dependent on downstream signaling events and 
changes during development. For example, in double positive thymocytes, peptides 
which do not activate mature peripheral T cell are sufficient to induce negative 
selection [105], and antagonist peptides that normally inhibit effector T cells are 
sufficient to induce positive selection [106]. Although the latter study focused on 
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 CD8+ T cell positive selection, one could envision that CD4+ SPs just after transition 
from the DP stage still have an enhanced ability to respond to low affinity antigen. This 
would allow agonist-ligand induced Treg induction, but the same TCR-peptide 
interaction would not drive peripheral proliferation after cloning into hybridomas, as 
done by Pacholcyzk et al. in the study mentioned above [103]. 
That Treg specific alterations of TCR signaling are important for their development has 
been suggested for a mutation in the adaptor molecule LAT (linker of activated T cells), 
but recent studies have cast doubt on this hypothesis [73]. However, costimulation via 
CD28 is known to be important for thymic Treg development and might influence TCR 
signaling as well [57]. 
 
 
6.2.6 INTEGRATING EXPERIMENTAL RESULTS AND CURRENT KNOWLEDGE INTO A MODEL 
Concerning the known literature and our own findings a model of agonist induced 
thymic Treg differentiation could be imagined as follows ( ).  Figure 20
After transition from the double positive to the single positive compartment, immature 
CD4+ SPs might still have an elevated sensitivity to react towards peptide-MHC class II 
complexes. Following antigen encounter (either on mTECs or DCs) the cells are either 
subject to clonal deletion, or Treg development is initiated, with the first steps being 
rapid upregulation of both CD25 and GITR and transcription of Foxp3 mRNA. Note that 
so far unknown signaling factors are likely to be involved at this step.  
Depending on the number of antigen presenting cells and the antigen level proliferation 
is initiated, which might be strong in the case of ubiquitous thymic self antigen, but only 
moderate for rare tissue restricted antigens. As mentioned above, proliferation might be 
necessary for demethylation of CpG motifs in the Foxp3 locus, which is crucial for 
sustained Foxp3 expression. 
After the initial activation step, some cells lose CD25 expression again, possibly 
depending on the contact to antigen presenting cells. Due to reduced expression of 
cytokine receptors for common gamma γ-chain cytokines (as shown by qPCR for IL2-
Rβ and IL7-Rα) cells at the CD25+/int Foxp3- stage require increased amounts of 
cytokines for their survival and continued differentiation. Through a combination of 
TCR- and cytokine-derived signals, CD25int cells express Foxp3 at protein level. This 
critical step might depend on other so far unknown factors, which could be provided by 
a hypothetical Treg niche within the thymic medulla, possibly involving surface 
molecules or secreted proteins provided by mTECs. In case a certain signaling 
threshold is reached, cells continue to develop to mature Foxp3+ Treg. 
For cells that continue to interact with antigen presenting cells, but not receive 
additional signals, proliferation might continue, while cells that have become activated, 
but do not receive appropriate survival signals, undergo apoptosis. Some cells might 
escape as autoreactive conventional T cells, but will be kept in check by Treg, which is 
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in line with the above mentioned study claiming that 40% of Treg TCRs are also found 
on conventional T cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: Model for agonist induced Treg development 
For detailed discussion, see main text. Note that some steps have not been directly shown, but can be 
proposed according to our own and published findings. Further experimentation is necessary to 
delineate the detailed mechanistics. 
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 6.3 IN VITRO CONVERSION AND TGF-β DEPENDENCE  
Understanding thymic Treg development would be facilitated if the in vivo process 
could be mimicked in vitro. We could show by cocultivation of ex vivo isolated thymic 
APCs with naïve CD4+ SPs, that both mTECs and thymic DCs are capable of Foxp3+ 
induction in vitro. 
Previous in vivo experiments in our lab have shown that antigen presentation by 
mTECs is sufficient for driving Treg development [58]. In contrast, other reports 
suggested the involvement of different stromal cell types [107, 96]. In the light of our in 
vitro observations there might be some redundancy between different thymic APCs in 
their principal capacity of supporting Treg induction, offering an explanation for these 
conflicting reports. 
Importantly, the efficiency of Treg induction depended on the concentration of the 
agonist peptide. As we have shown earlier, mTECs and DCs do not markedly differ in 
the strength of delivered “signal one” [58], suggesting that additional factors such as 
unknown costimulatory molecules might be involved. 
Concerning the involvement of TGF-β, our results support the recently published 
hypothesis that TGF-β serves a more elemental role in Treg development than initially 
thought. However, stimulation of T cells by splenic APCs or anti-CD3/CD28 antibodies 
has not been reported to induce Treg in the absence of TGF-β, while mTECs and to 
some extend thymic DCs were capable of driving Foxp3 induction even after inhibition 
of TGF-β signaling. Therefore, there might be considerable overlap in the mechanistic 
aspects of peripheral and thymic Treg development, but both thymic APC types might 
be equipped with particular abilities for supporting Treg development. 
To elucidate the involvement of previously unknown factors such as soluble or 
membrane bound molecules, our in vitro model of Treg induction could provide a 
suitable defined experimental system. 
 
 
6.4 CONCLUSION AND FUTURE PERSPECTIVES 
Our experimental results unravelled several steps in the agonist driven development of 
naïve CD4+ SP to Foxp3+ Treg and identified CD25+ Foxp3- CD4+ SPs as direct 
precursors of mature Foxp3+ Treg cells.  
However, a number of questions remain to be clarified, in particular how the decision is 
made whether a developing T cell is deleted or deviated into the Treg lineage. 
According to our model a combination of TCR- and cytokine-derived signals allow Treg 
induction, with the developmental stage being an additional crucial factor. 
Gene expression profiling of the TCR-HA+ subsets found in AIRE-HA × TCR-HA mice 
could provide insight into the T cell side of this process, revealing which transcription 
factors are upregulated after antigen exposure, but prior to Foxp3 expression. 
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Additional in vivo transfer studies using mice deficient in factors known to be involved 
could show which signals are required at which developmental stage. Using this 
experimental approach the role of CD28 costimulation is currently investigated in our 
lab (M. Hinterberger, personal communication). 
The most promising approach for studying the importance of single factors are in vitro 
studies. Using for example neutralizing antibodies to both soluble factors and surface 
molecules one could study the required cytokine milieu within a defined system. 
 
 
 
 7 ABBREVIATIONS 
A summary of used abbreviations (in alphabetical order) is given below. 
 
 
AIRE autoimmune regulator 
ALK activin-receptor like kinases  
APC antigen presenting cell 
BM bone marrow 
CD cluster of differentiation 
cDNA complementary DNA 
CFSE carboxy-fluorescein diacetate succinimidyl ester  
DC dendritic cell 
DN double negative 
DP double positive 
FACS flourescence activated cell sorter 
FCS fetal calf serum 
Foxp3 forkhead box P3 
GITR glucocorticoid induced tumor necrosis factor receptor 
HA hemagglutinin 
ICOS inducible T cell costimulator 
IL interleukin 
IPEX immune dysregulation, polyendocrinopathy, X-linked 
IT intrathymic 
JAK janus kinase 
LN lymph node 
MHC major histocompatibility complex 
mTEC medullary thymic epithelial cell 
NFAT nuclear factor of activated T cells 
NFkB nuclear factor kappa b 
OVA ovalbumin 
PCR polymerase chain reaction 
PD1 programmed death 1 
RAG recombination activating gene 
RTE recent thymic emigrants 
SOCS suppressor of cytokine signaling 
SP single positive 
STAT signal transducer of activated T cells 
TCR T cell receptor 
TGF transforming growth factor 
Treg  regulatory T cell 
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